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SUMMARY    
Developmental biology studies the process by which a single cell, the zygote, will have 
to divide thousands of times to generate a huge number of specialized cells that 
comprise the whole adult organism. 
The first distinction between cell types that occurs after fertilization is the formation of 
the trophectoderm and the inner cell mass. These are two essential cell populations in 
development: the trophectoderm is the precursor of the placenta while the inner cell 
mass will give raise to the rest of specialized cells of the embryo and the adult 
organism. Before generating these two lineages, all cells are equivalent and totipotent, 
i.e., they are capable of forming all structures (embryonic and extraembryonic) in the 
embryo. The first differentiation event occurs in the early stages of development of the 
embryo, before implantation in the uterus at the blastocyst stage. Segregation of 
trophectoderm from the inner cell mass in the blastocyst is key because, firstly, 
embryonic cells lose their totipotency and, moreover, a new tissue is produced, the 
trophectoderm, which is characteristic of mammals. The trophectoderm generates the 
trophoblast, which after differentiating into multiple cell types forms the placenta and 
amniotic membranes. 
Cdx2 is the key gene in the segregation between trophectoderm and the inner cell 
mass. We identify a regulatory element involved in the regulation of Cdx2. This 
regulatory element directs expression of a marker gene specifically to the 
trophectoderm. The regulatory element characterized will be crucial to understand the 
information that Cdx2 receives and processes to activate and exert its functions. In 
addition, we find that its activity is stage-specific and does not drive expression of the 
marker gene in other tissues where also Cdx2 is expressed. Finally, we find that the 
Notch signalling pathway is involved in trophectoderm formation together with Tead4, 
a gene recently involved in this first decision. Thus we characterize the joint and parallel 
regulation of Notch and Tead4 on the identified Cdx2 regulatory element, such that it 
ensures the proper development of the embryo in which compensatory mechanisms 
promote embryo viability. 
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RESUMEN    
La biología del desarrollo estudia el proceso por el que una única célula, el zigoto, se 
divide para generar un número muy elevado de células especializadas que forman la 
diversidad de tejidos que encontramos en el adulto. 
La primera distinción entre tipos celulares que ocurre tras la fecundación es la 
formación del trofectodermo y la masa celular interna. Se trata de dos tejidos 
esenciales en el desarrollo: el trofectodermo es el tejido precursor de la placenta 
mientras que la masa celular interna es el tejido que formará el resto de células 
especializadas del embrión y del organismo adulto. Antes de que el embrión genere los 
dos tejidos, todas las células que lo forman son equivalentes y totipotentes, es decir, 
son capaces de formar todas las estructuras (embrionarias y extraembrionarias) del 
embrión. Este primer evento de diferenciación ocurre antes de la implantación en el 
útero materno en el estadio de blastocisto. La segregación del trofectodermo y la masa 
celular interna en el blastocisto es clave ya que, por un lado, las células embrionarias 
pierden su totipotencialidad y, por otro lado, se genera un tejido, el trofectodermo, que 
es característico de mamíferos. Del trofectodermo se origina el trofoblasto que, tras 
diferenciarse a varios tipos celulares, forma la placenta y las membranas amnióticas. 
Cdx2 es el gen central en la segregación del trofectodermo frente a la masa celular 
interna. En este trabajo identificamos un elemento regulador implicado en la función 
de Cdx2. En concreto, este elemento regulador dirige la expresión de un gen marcador 
de una manera restringida al trofectodermo, siendo esencial para comprender la 
información que recibe y procesa Cdx2 para activarse. Además, detectamos que su 
actividad es estadio-específica ya que no dirige la expresión del gen marcador en otros 
tejidos donde Cdx2 también se expresa. Finalmente, identificamos que la vía de 
señalización de Notch está implicada en la formación del trofectodermo junto con 
Tead4, un gen recientemente implicado en esta primera decisión. De esta manera 
caracterizamos que la regulación conjunta y en paralelo de Notch y Tead4 se procesa 
sobre el elemento regulador de Cdx2 identificado, de tal forma que se garantiza el 
correcto desarrollo. Estos resultados demuestran que existen mecanismos de 
compensación en estos estadios de desarrollo para favorecer la viabilidad del embrión. 
  
  
  
 xix 
INDEX    
ACKNOWLEDGEMENTS IX 
SUMMARY XV 
RESUMEN XVII 
INDEX XIX 
LIST OF FIGURES XXIII 
LIST OF ACRONYMS XXV 
INTRODUCTION 3 
1. Preimplantation development. . . . . . . . . . . . . . . . . . . . . .  3 
2. Where and when are the first lineages established? . . . . . . . . . . . . .  5 
3. Transcriptional circuitry driving cell fate in the preimplantation embryo. . . . . . .  8 
4. The first lineage choice and the Hippo pathway. . . . . . . . . . . . . . .  12 
5. Deconstructing transcriptional circuits in the preimplantation embryo. . . . . . .  14 
6. Embryo derived stem cell populations. . . . . . . . . . . . . . . . . . .  16 
7. The Notch pathway and the control of cell fate . . . . . . . . . . . . . . .  18 
OBJECTIVES 21 
MATERIALS & METHODS 25 
1. Construct generation for microinjection . . . . . . . . . . . . . . . . .  25 
2. Transient transgenic analysis . . . . . . . . . . . . . . . . . . . . .  25 
3. Generation of TEE mouse lines . . . . . . . . . . . . . . . . . . . . .  26 
4. Mouse breeding . . . . . . . . . . . . . . . . . . . . . . . . . .  27 
5. Embryo collection and culture . . . . . . . . . . . . . . . . . . . . .  27 
6. Mutagenesis . . . . . . . . . . . . . . . . . . . . . . . . . . .  28 
7. Pharmacological inhibitor treatments . . . . . . . . . . . . . . . . . .  28 
8. Cell culture . . . . . . . . . . . . . . . . . . . . . . . . . . . .  28 
 xx 
9. Immunohistochemistry . . . . . . . . . . . . . . . . . . . . . . .  29 
10. Quantitative-PCR . . . . . . . . . . . . . . . . . . . . . . . . .  29 
11. Cell transfections. . . . . . . . . . . . . . . . . . . . . . . . . .  30 
12. Histone ChIP . . . . . . . . . . . . . . . . . . . . . . . . . . .  31 
13. TS cell derivation . . . . . . . . . . . . . . . . . . . . . . . . . .  32 
 TSL cells genotyping . . . . . . . . . . . . . . . . . . . . . .  32 13.1
 TSR and TSL cell expression profile . . . . . . . . . . . . . . . . .  32 13.2
 TS derived cell cycle profiling . . . . . . . . . . . . . . . . . . .  32 13.3
14. TS cell infection . . . . . . . . . . . . . . . . . . . . . . . . . .  33 
15. TS cell injection . . . . . . . . . . . . . . . . . . . . . . . . . .  34 
16. Imaging and quantification . . . . . . . . . . . . . . . . . . . . . .  34 
17. Statistics . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  34 
RESULTS 39 
1. Identification of a trophectoderm-specific Cdx2 enhancer. . . . . . . . . . . .  39 
2. Characterization of the Cdx2 TEE mouse lines. . . . . . . . . . . . . . . .  41 
3. TEE behaviour in trophoblast stem cells as a model of TEE function upon implantation .  46 
 TS cell transfections of regulatory elements. . . . . . . . . . . . . . .  46 3.1
 Analysis of the Cdx2 epigenetic landscape. . . . . . . . . . . . . . .  47 3.2
 TS derivation from mRFP- and lacZ-TEE mouse lines. . . . . . . . . . .  48 3.3
4. Searching for known upstream regulators of Cdx2 that act through the TEE. . . . .  51 
 Analysis of the TEE response to CDX2 and OCT4. . . . . . . . . . . . .  52 4.1
 Analysis of the mRFP-TEE line response to the Hippo pathway. . . . . . . .  54 4.2
5. Searching for unknown upstream regulators of Cdx2 that act through the TEE.. . . .  57 
 Characterization of the Notch pathway in early preimplantation. . . . . . .  57 5.1
 Notch activity in TS cells. . . . . . . . . . . . . . . . . . . . .  60 5.2
 Functionality of the identified TEE RBPJ and TEAD binding sites. . . . . . .  61 5.3
6. Does the Notch signalling pathway together with Tead4 regulate Cdx2 trough the TEE? 64 
7. Analysis of a Notch gain of function model. . . . . . . . . . . . . . . . .  69 
 Cdx2 expression analysis of RosaNotch overexpressing blastomeres. . . . . . .  70 7.1
 Rosa Notch overexpressing blastomeres allocate preferentially in the TE of the 7.2
blastocyst. . . . . . . . . . . . . . . . . . . . . . . . . . . . .  72 
DISCUSSION 77 
 xxi 
1. Two-stage regulation model for Cdx2. . . . . . . . . . . . . . . . . . .  77 
2. Notch and Hippo converge on Cdx2 regulation through the TEE. . . . . . . . .  81 
3. Notch signalling in the first lineage choice. . . . . . . . . . . . . . . . .  85 
CONCLUSIONS 91 
CONCLUSIONES 93 
BIBLIOGRAPHY 95 
SUPPLEMENTARY TABLES 115 
PUBLICATIONS 119 
 
  
 
  
 xxiii 
LIST OF FIGURES    
Figure 1. Stages in early preimplantation development . . . . . . . . . . .   5 
Figure 2. Models of lineage formation . . . . . . . . . . . . . . . . .   7 
Figure 3. The self-organizing model . . . . . . . . . . . . . . . . . .   8 
Figure 4. Transcription circuitry involved in the first lineages in the blastocyst . . . .  11 
Figure 5. Differential distribution of Hippo pathway in the first lineage choice . . . .  14 
Figure 6. Core components in the Notch signalling pathway . . . . . . . . . . .  18 
Figure 7. Notch mechanisms in development and differentiation . . . . . . . . .  20 
Figure 8. Characterization of TSL and TSR cells . . . . . . . . . . . . . . . .  33 
Figure 9. A cis-regulatory element drives restricted expression in the trophectoderm . .  40 
Figure 10. Fragments tested by transient transgenesis in the blastocyst . . . . . . .  41 
Figure 11. mRFP- and lacZ-TEE lines drive restricted expression in the trophectoderm . .  43 
Figure 12. Cdx2 TEE reproduces the early onset of CDX2 expression . . . . . . . .  44 
Figure 13. Cdx2 TEE is inactive in the post-implantation embryo . . . . . . . . . .  45 
Figure 14. Cdx2 regulatory landscape analysis in TS cells . . . . . . . . . . . .  48 
Figure 15. TSR cells do not drive reporter activity . . . . . . . . . . . . . . .  49 
Figure 16. TSR cells drive mRFP reporter expression in blastocysts . . . . . . . . .  50 
Figure 17. The TEE is not an autoregulatory element . . . . . . . . . . . . . .  52 
Figure 18. The TEE does not respond to OCT4 . . . . . . . . . . . . . . . .  54 
Figure 19.  The Hippo pathway is not sufficient to regulate the TEE . . . . . . . . .  56 
Figure 20. Identification of putative RBPJ binding sites . . . . . . . . . . . . .  57 
Figure 21. The Notch signalling pathway is active in the trophectoderm . . . . . . .  59 
Figure 22. TS cells contain N1ICD heterogeneous levels . . . . . . . . . . . . .  61 
Figure 23. RBPJ together with TEAD binding sites are necessary for the TEE . . . . . .  62 
Figure 24. Notch and Hippo are responsible for full enhancer activity . . . . . . . .  63 
Figure 25. Verteporfin treatment phenocopies Tead4 -/-.. . . . . . . . . . . . .  64 
Figure 26. TEE activity and Cdx2 expression require inputs from Notch and Hippo . . .  66 
Figure 27. Rbpj and Tead4 happloinsuficient embryos show reduced TEE+ cells . . . .  67 
Figure 28. Cdx2 expression requires transcriptional inputs from Notch and Hippo . . .  68 
Figure 29. TEE activity is reduced by VP + RO treatment . . . . . . . . . . . . .  69 
Figure 30. Rosa Notch gain of function model . . . . . . . . . . . . . . . . .  70 
Figure 31. Mosaicism of maternal Sox2-Cre activity in the blastocyst . . . . . . . .  71 
Figure 32. Notch overexpression regulates Cdx2 expression . . . . . . . . . . .  72 
Figure 33. Notch instructs cells to adopt an outer position in the blastocyst . . . . . .  73 
Figure 34. Two-stage regulation model of Cdx2. . . . . . . . . . . . . . . .  81 
Figure 35. Notch and Hippo converge on Cdx2 to specify trophectoderm lineage . . .  84 
Figure 36. Temporal control of TE specification through the Notch and Hippo pathways .  88 
  
  
  
 xxv 
LIST OF ACRONYMS    
5TVER7 Tead4VP16 tamoxifen- inducible ES cell line  
BAC Bacterial Artificial Chromosome 
bp Base pairs 
Cdx2 -/- Cdx2 knockout 
ChIP Chromatin immunoprecipitation 
DMSO Dimethyl sulfoxide 
dpc days post coitum 
EMFI Mouse Embryonic Fibroblasts Inactivated  
EMFI-CM EMFI Conditioned Media 
ExE Extraembryonic Ectoderm 
H2BmRFP Histone 2B fused to the monomeric Red fluorescent protein 
HUVEC Human Umbilical Vein Endothelial Cells 
ICM Inner Cell Mass 
IRES Internal Ribosomal Entry site 
kb Kilobases 
mRFP monomeric red fluorescent protein 
N1ICD Notch1 Intracellular Domain 
N1OE Notch1 Overexpressing 
Oct4DE Oct4 distal enhancer 
qPCR quantitative PCR 
Rbpj -/- Rbpj knockout 
Rosa Notch Rosa26 locus encoding N1ICD-IRES-nEGFP 
Rosa YFP Rosa26 locus encoding YFP 
Tc Tetracycline 
TE Trophectoderm 
Tead4 -/-  Tead4 knockout 
Tead4VP16 Constitutively active Tead4 
TEE  Trophectoderm Enhancer 
TS Trophoblast stem cells 
TSL lacZ-TEE derived TS cells 
TSR mRFP-TEE derived TS cells 
ZHBTc4 Oct4 tetracycline -repressible ES cell line  

 1 
 
 
 
 
 
 
 
 
“If you don't know where you are going, any road will take you there.” 
Alice in Wonderland. LEWIS CARROLL. 
  
  
 
  
 3 
INTRODUCTION    
Developmental biology studies the process by which a single cell, the zygote, divides 
thousands of times to generate a huge number of specialized cells that comprise the 
whole adult organism, in humans ~1012 - 1014 cells. The formation of a new organism 
during embryogenesis is a spectacular process and represents a masterpiece of 
temporal and spatial control of gene expression. 
Placental mammalian development occurs within the mother’s reproductive tract in two 
separate phases. Initially, the embryo develops from the one-cell to the blastocyst stage 
freely (Figure 1), to then attach to the uterine wall and implant in order to receive 
maternal nourishment and growth cues. The first preimplantation phase occurs over 4 
to 5 days in the mouse and 6 days in humans. As the preimplantation embryo is 
independent of external requirements, it is possible to easily recapitulate 
preimplantation development in culture using chemically defined media without the 
need of added growth factors. The first specialized tissues that are defined in 
mammalian embryo development are the extraembryonic cell lineages, the 
Trophectoderm (TE) and Primitive Endoderm (PE), which will form the placenta and 
amniotic membranes, essential for the interchange of nutrients and other material with 
the maternal uterine environment. Extraembryonic structures do not contribute to the 
fetal tissue; they support embryo growth and provide signals for patterning. 
1. Preimplantation development. 
Mammalian development is a regulative model in which the cues for differentiation are 
formed while the embryo develops, and in which cells initially can adopt any possible 
fate during the first three days. These observations indicate that early mouse 
development is ruled by a relatively labile developmental program. How the zygote is 
able to retain this flexibility and at the same time produce its first different cell types is 
key to understanding how development proceeds. 
Upon fertilization, the unicellular mammalian zygote undergoes a series of equal cell 
divisions (cleavage divisions) in which it increases cell number but not net size (Figure 
1). It is surrounded by a glycoprotein envelop, the zona pellucida, essential in the 
fertilization process. The zona protects the developing zygote and constrains its space 
during cleavage. The cells –known as blastomeres-, are interchangeable until the eight 
cell stage (reviewed in Johnson and McConnell, 2004), which allows development to 
proceed even if blastomeres are destroyed during these early stages (Tarkowski, 1959; 
Suwinska et al., 2008). The first cleavage division forms the two-cell stage embryo 
characterized by the switch from maternal to zygotic transcription. 
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From the two cell stage up to the next successive two division rounds, each blastomere 
retains full competence to develop into any specialized cell, extraembryonic tissues 
included; blastomeres appear morphologically identical, sharing a spherical and 
symmetrical shape. As cleavage proceeds, blastomeres get smaller and the embryo as a 
whole adjusts its position constantly within the zona. 
The first morphological differences arise at compaction: embryos increase their cellular 
adhesion and their surface smoothens (Figure 1). At the same time, blastomeres 
polarize thus losing their symmetry. In the subsequent divisions -from the 16- to 32-cell 
stage, some cells occupy inner positions within the embryo and remain apolar, whereas 
some others remain in the periphery and polarize along the apico-basal (outside-
inside) axis. Tight junction maturation between outer cells from the 32-cell stage 
enables embryo cavitation -the generation of a large fluid-filled cavity (blastocoel) 
within the early embryo. Cavitation starts in essentially every apico-basally polarized 
outer blastomere. Cytoplasmic vesicles within the cells secrete fluid into the intercellular 
space, thus creating extracellular cavities. These fluid cavities locate beneath outer 
blastomeres and gradually merge to form bigger cavities as a result of the sealing of 
epithelial blastomeres. Blastocoel expansion imposes a physical constraint on the 
embryo, deforms blastomere shape and is resolved in the blastocyst, where the 
blastocoel locates at one end of the long axis (Fleming and Pickering, 1985; Motosugi 
et al., 2005). 
At the blastocyst stage the two first lineage populations can be clearly distinguished. 
The trophectoderm (TE) is the epithelial external tissue surrounding the group of cells 
sitting on top of the cavity termed the Inner Cell Mass (ICM) from where the embryo 
proper will develop. The TE will give rise to extraembryonic structures, mainly the 
placenta (Rossant and Tam, 2009). The final event in blastocyst formation is the 
segregation of a monolayer of primitive endoderm on the blastocoelic surface of the 
ICM by 4.5 dpc, enclosing the remaining pluripotent epiblast progenitors. By this stage, 
the embryo is ready to implant in the uterus, and the complex events leading to 
gastrulation and axis formation begin. 
Where and when are the first linages established? 
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Figure 1. Stages in early preimplantation development. 
Overview of mouse preimplantation development during embryonic stages 0.5 – 4.5 dpc 
(days post coitum). Following fertilization the early mouse embryo undergoes a series of 
cleavages to generate the lineages necessary for in utero survival. Upon compaction, 
apico-basal polarization of outer cells (depicted in blue) generates the first morphological 
difference.  
The first lineage choice is thus a distinction that occurs progressively as development 
proceeds, starting in the morula and continuing up to the blastocyst stage. The 
complex mechanisms involved and the timing of this decision are still under debate. 
2. Where and when are the first lineages established? 
Classically, three models exist to explain TE and ICM segregation: the pre-patterning 
model, the inside-outside model and the polarity model (Figure 2). 
In the pre-patterning model, TE and ICM are generated upon the asymmetrical 
distribution of molecular determinants in the oocyte in analogy to other model 
organisms; in this model, cells would have a fixed fate as soon as they are originated. In 
this context, pre-patterning arises from a fixed orientation in division planes or the 
sperm entry position, because so far no molecules have been found that explain 
lineage segregation in the regulative embryo. Nonetheless, there are some reports in 
which lineage tracing of cells shows a preferential allocation of lineages (Piotrowska-
Nitsche and Zernicka-Goetz, 2005; Tabansky et al., 2013), supporting a bias in the 
lineage decision. 
The inside-outside model suggests that a cell’s position leads to different amounts of 
cell contact and different microenvironments that are interpreted to establish cell fate 
(Tarkowski, 1959). In this way, the inside environment is the key factor to ensuring 
lineage segregation, and the outside polarized epithelia confers support for inner cells 
and is important to ensure the inside niche. In this model, position distinguishes the 
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two populations, rather than the segregation of determinants, and establishes that the 
prospective TE protects the future pluripotent cells as soon as two populations arise in 
the embryo. 
The polarity model suggests that the acquisition of cell polarity at the eight-cell stage is 
critical for lineage segregation in the next cleavage stages (Johnson and Ziomek, 1981). 
In the model, apolar cells generate inside cells as they divide, whereas cleavage of a 
polarized cell leads to the inheritance of the apical pole in the daughter cells. In this 
way, symmetric cleavage of polarized cells generates two daughter cells that inherit the 
polarizing cues thus contributing to outer cells, the future TE. In contrast, asymmetric 
division of a polarized cell generates two distinct daughter cells, one polar (future TE 
cell) and the other apolar (future ICM cell). (Summarized in Figure 2 and reviewed by 
Rossant, 2009 ; Wennekamp et al., 2013; Yamanaka et al., 2006). 
Recent molecular and genetic studies suggest that a combination of the cell polarity 
and inside-outside models seems more likely to be operating, as would be inhibited by 
polarity in outside cells and activated by cell adhesion in inside cells (Manzanares and 
Rodriguez, 2013). Nevertheless, a considerable body of results is not compatible with 
any of the proposed models. For instance, live-imaging technology has shown cell 
rearrangements during preimplantation development, whereas none of the proposed 
models considers any change in cell allocation when outside and inside cells are 
formed (Watanabe et al., 2014) (Bischoff et al., 2008; McDole et al., 2011; Plusa et al., 
2008). Also, careful analysis of protein positioning and quantitative analysis of mRNA 
expression at single-cell resolution has shown heterogeneous expression of key 
transcription factors (Dietrich and Hiiragi, 2007; Guo et al., 2010; Tang et al., 2009). The 
heterogeneous expression of transcription factors indicates that cell fate is plastic even 
after the first morphological differences arise. This is not compatible with models in 
which single events lead to a lineage choice. Additionally, the analysis of OCT4 protein 
kinetics indicated that differences in protein kinetics, instead of the total protein 
amount, might influence lineage choice (Plachta et al., 2011). 
Where and when are the first linages established? 
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Figure 2. Models of lineage formation. 
(A) The pre-patterning model proposes that the TE and ICM lineages are segregated on 
the basis of molecular determinants that are asymmetrically localized in the oocyte 
(exemplified in red and green gradients). During subsequent cleavages, these 
determinants are differentially segregated between daughter cells and determine cell fate. 
Single cells are depicted in dark grey and their nucleus is coloured according to their 
prospective fate (red, TE; green, ICM). 
(B) The inside–outside model proposes that, at the 16-cell stage, cell position of the 
outside or inside in the late morula determines fate in the blastocyst. In the next division 
round, outer cells polarize (apico-basal domains depicted in blue). Single cells are 
depicted in dark grey (nucleus, light grey). 
(C) The cell polarity model proposes that, at the eight-cell stage, cell polarity and 
cleavage patterns lead to the establishment of outside (blue contour) and inside (rounded 
grey) cells at the 16-cell stage. Symmetric cleavage of polarized cells (blue outline) 
produces two outside cells (vertical dashed line), whereas asymmetric cleavage produces 
one outside and one inside cell (horizontal dashed line in polarized cells). 
Recently, a self-organizing model has been put forward that incorporates all available 
data (Figure 3). It can also explain observations that are not considered in the previous 
models, such as the stochastic expression of transcription factors or the 
interdependence between cell polarity and the activity of signal transduction pathways 
involved in lineage choices (Wennekamp et al., 2013). 
In this model, lineage establishment is initiated, corrected and refined by several 
factors, including transcription factors and sensors of morphology in cells. The model 
postulates that each of these factors makes a specific contribution to enforce the 
expression of lineage-specific genes. Importantly, their relevance varies with the 
context, and some factors can be dispensable or dominant according to the situation. 
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Another essential feature is the interconnection and interdependence of these factors 
to regulate each other. Thus, the self-organizing model provides a general framework 
that covers the physical properties of the cell, differential gene expression patterns and 
the localization of molecules. In conclusion, it is a working model that includes most of 
the parameters described so far that account for preimplantation development. 
Figure 3. The self-organizing model. 
In the regulative embryo, a combination of cell 
features drives blastomere arrangement to 
finally generate the TE and ICM segregation. 
The local microenvironment can influence the 
activity of gene expression (ICM gene 
expression is depicted in green and TE-specific 
gene expression in red). Also, gene expression 
can modify the cell’s physical properties 
(features depicted in black). Feedback loops 
stabilize the state of the cell and adjust the 
final output. 
3. Transcriptional circuitry driving cell fate in the preimplantation 
embryo. 
Transcription factors orchestrate the destiny of cells as they are proteins that bind DNA 
and regulate the expression of downstream genes. Transcription factors promote a 
specific transcriptional program that is ultimately responsible for the identity of a cell. 
The specification of the first lineages occurs as a small set of transcription factors 
becomes restricted to distinct populations. This is a progressive process in which 
transcription factors appear to be operating in three separate phases: initiation, 
commitment and maintenance. During initiation, a homogenous population starts to 
show molecular heterogeneities. Differences can appear either stochastically or through 
subtle external cues. During initiation, as reported in other systems (Zaret and Carroll, 
2011), pioneering factors that can directly bind condensed chromatin might be 
important for transcription and initiation of lineage determination. In the commitment 
phase, transcription factors respond in coordination with cellular signals and activate 
downstream genes, and at the same time form positive feedback loops that strengthen 
their expression. At these stages, lineage choice is still plastic and a cell can switch fate 
according to its context. In the final maintenance phase, the transcription factor 
regulatory network is assembled to maintain its transcriptional status and impede any 
unwanted lineage switch. 
Transcriptional circuitry driving cell fate in the preimplantation embryo 
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In the last decade, the core set of transcription factors involved in the first lineage 
choices in the mammalian embryo has been identified. Table A (Supplementary Table) 
lists the main transcription factors involved in TE and ICM segregation. 
In preimplantation development, the TE and ICM appear upon compaction, the 
commitment phase, and it is only at the blastocyst stage that they are properly 
established as the two first different lineages of the embryo. The TE and ICM will only 
get irreversibly segregated when expression of the core transcription factors is 
sustained by positive feedback loops and cross-regulatory repression at the blastocyst 
stage. To date, the key transcription factors identified as a part of the TE regulatory 
network are Cdx2, Tead4, Gata3 and Eomes. The key regulators of ICM establishment 
are Oct4, Sox2 and Nanog. TE and ICM are thus the two first specialized cell types that 
are formed during development. Still, both tissues retain fully potency to differentiate 
into many tissues: the TE will differentiate into trophoblast and subsequently to most of 
the placental tissues of embryonic origin, and the ICM will give rise to the epiblast and 
primitive endoderm one day later, and form all the tissues of the fetus and the adult 
organism and part of the extraembryonic structures. 
The homeodomain transcription factor Cdx2 is the first marker detected (Figure 4A). It 
is expressed in a salt and pepper manner at the eight cell stage and progressively 
restricts its expression to outer cells and the TE before Oct4, Nanog, and Sox2 
expression is restricted to the ICM (Dietrich and Hiiragi, 2007). Remarkably, the Cdx2 
spatial restriction previous to that of Oct4, Nanog and Sox2 suggests that it may be 
required to downregulate these three transcription factors in outer cells. Additionally, 
Cdx2 mutant (Cdx2 -/-) embryos die at 3.5 dpc as they fail to form an expanded 
blastocyst that maintains its epithelial integrity. In these mutants, Oct4 and Nanog are 
ectopically expressed and not properly restricted in outside cells at the blastocyst stage 
(Chawengsaksophak et al., 1997; Strumpf et al., 2005). 
It has been proposed that differences in the expression levels of Cdx2 influence cell 
polarity and account for TE initiation. An asymmetric distribution of Cdx2 mRNA would 
result in asymmetric cell division in which daughter cells with low levels of Cdx2 
contribute to ICM, whereas cells with high levels of Cdx2 form the TE (Jedrusik et al., 
2008). However, there is evidence that neither maternal nor zygotic Cdx2 transcripts 
direct the initiation of ICM/TE lineage separation (Ralston and Rossant, 2008; Wu et al., 
2010) and Cdx2 mutation does not lead to complete failure to initiate the formation of 
the TE epithelium of the blastocyst (Ralston and Rossant, 2008; Strumpf et al., 2005); 
thus, how TE fate is initiated still remains to be resolved. 
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The ICM marker Oct4 is ubiquitously expressed early on. It is gradually restricted to the 
ICM at 4.5 dpc (Figure 4A). Oct4 is crucial for stabilizing the ICM, such that all cells of 
Oct4 deficient embryos convert to TE (Nichols et al., 1998). The pluripotency gene 
Nanog exhibits highly variable levels and gets restricted to the epiblast at 4.5 dpc 
(Figure 4A). Nanog mutants fail to generate the epiblast and their ICM only produces 
primitive endoderm cells (Mitsui et al., 2003). Importantly, neither factor is predictive of 
lineage segregation: the ubiquitous expression of Oct4 discards the factor as a possible 
early marker of ICM segregation, and the variability in Nanog levels is independent of 
position within the morula. Additionally, there is no initial correlation in the mosaic 
expression of Cdx2 with Oct4 or Nanog (Dietrich and Hiiragi, 2007). A recent study 
suggests that OCT4 kinetics, rather than total transcription levels, is different before 
compaction among otherwise indistinguishable cells and that this may initiate TE/ICM 
segregation in the early mouse embryo (Plachta et al., 2011). The other main 
pluripotency factor Sox2 is present together with Oct4 in the early blastomeres (Ralston 
and Rossant, 2008), but unlike Oct4, Sox2 remains present in TE cells (Adachi et al., 
2013). Sox2 expression has been suggested as the earliest ICM marker by 
transcriptional profiling (Guo et al., 2010) and Sox2 mutants produce a failure at 
implantation due to defects in epiblast and extraembryonic ectoderm (Avilion et al., 
2003). 
After TE and ICM commitment, these expression patterns are maintained by reciprocal 
repression of Oct4 by Cdx2 in the TE (Niwa et al., 2005), and repression of Cdx2 by 
Oct4, Nanog, and Sox2 (Boyer et al., 2005; Loh et al., 2006) in the ICM, together with 
the auto regulation of Oct4 and Cdx2 (Chew et al., 2005). 
In conclusion, the transcriptional circuitry regulating TE and ICM fates is crucial for the 
establishment of the two lineages; however, their expression does not completely 
correlate with the first distinction in the populations. Moreover, these regulatory 
networks and their cross-regulation do not explain how the outside and inner 
populations appear. 
Transcriptional circuitry driving cell fate in the preimplantation embryo 
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 Figure 4. Transcription circuitry involved in the formation of the first 
lineages in the blastocyst. 
(A) The initial expression of Cdx2, Oct4 and Nanog transcription factors in the eight cell 
stage is not restricted to specific cell populations. At the 16-cell stage, outer (dark grey) 
and inner populations (light grey) arise as a consequence of compaction and 
polarization. CDX2 protein is detected beginning at the eight- to 16-cell stage; its initial 
expression is stochastic. By the morula to early blastocyst stages, Cdx2 expression is 
higher in outer, apically polarized cells. Restricted expression in TE cells is established 
by the blastocyst stage. OCT4 protein is observed in all blastomeres throughout early 
cleavage stages. It is not until the blastocyst stage that Oct4 is gradually 
downregulated in the TE and restricted to the ICM. NANOG is detected from the eight-
cell stage. It is expressed in a mosaic fashion in cells until the blastocyst stage. It is then 
restricted to the ICM; next, Nanog-positive will segregate to form the epiblast. (B) The 
core components of the Hippo pathway YAP and TEAD4 translate the maturation of 
cellular structures into a transcriptional response. TEAD4 is ubiquitously expressed in 
these stages and its TE-specificity depends on its coactivator YAP. YAP is ubiquitously 
expressed in the nuclei of the eight-cell stage embryo. Inner cells promote YAP 
sequestration in the cytoplasm favouring ICM formation; in contrast, polarization in 
outer cells allows translocation of YAP to the nucleus to promote TE specification. 
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4. The first lineage choice and the Hippo pathway. 
The first cell fate decision in the mouse embryo takes place during the transition from 
morula to early blastocyst when the first morphological differences arise. The processes 
of compaction, polarization, and asymmetric divisions take place at the time that 
lineage specific transcription factors become spatially restricted and TE and ICM 
become segregated. 
It remains unclear how compaction is initiated. Compaction is associated with the 
formation of adherens junctions in regions of cell-to-cell contact mediated through E-
cadherin, as shown by the precocious compaction when cells are supplied with high 
exogenous levels (Dietrich and Hiiragi, 2007) and failure of maternal/zygotic E-cadherin 
mutants to compact (Stephenson et al., 2010). These mutants present an incorrect 
TE/ICM cell positioning, confirming that epithelial integrity is essential for the lineage 
choice; however, Cdx2 expression is maintained, discarding cell adhesion mediated 
events as early upstream regulators of Cdx2. Polarization is concomitant with 
compaction. Polarization is the asymmetric distribution of molecules and organelles 
into the apical and basolateral domains. In morulae, the apical domain faces the surface 
whereas the basolateral domain remains inside. Polarization is key to the divergence of 
the first lineages, since the apical domain acts as a signal to promote differentiation of 
the TE. Although there is a clear relationship between polarization and cell adhesion, 
isolated blastomeres can form distinct apical and basal domains, suggesting that other 
mechanisms are responsible for polarization (Cockburn and Rossant, 2010). 
Additionally, in the division from the eight- to the 16- cell stage, a population of inner 
cell arises. This inside population is smaller than that of apolar cells, indicating that 
some outer cells are apolar. Thus, polarization and inside-outside positioning are two 
distinct processes at the eight to 16- cell stage (Anani et al., 2014). 
In recent years, the molecular link between polarization and cell fate in the 
preimplantation embryo has started to be understood. The Hippo signalling pathway 
has been shown to act as a sensor of polarization in polar versus apolar cells in 16-cell 
embryos. Hippo pathway components redistribute in different subcellular domains in 
polar and apolar populations, and thus drive the activation of lineage-specific gene 
expression programs. The first evidence for the pathway having a role came when it 
was found that Tead4 mouse mutants die at the blastocyst stage. Although TEAD4 is 
expressed in all cells of the blastocyst (Figure 4B), mouse mutants have defects in the 
specification and development of the TE, do not form a blastocoel and show decreased 
expression of TE markers Cdx2 and Gata3. In contrast, the ICM seems unaffected in 
Tead4 mutant embryos, since expression of ICM-specific Oct4 and Nanog is detected in 
The first lineage choice and the Hippo pathway 
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Tead4 mutant embryos, and ES cells can be established from them (Nishioka et al., 
2008; Ralston et al., 2010; Yagi et al., 2007). 
The Tead family of transcription factors requires a transcriptional co-activator to 
stimulate downstream gene expression. The co-activator of TEAD and downstream 
effector of the Hippo pathway is the Yes-associated protein (YAP). This signalling 
pathway, which is conserved from Drosophila to mammals, is a major regulator of cell 
growth, proliferation, apoptosis, and is critical for cell fate decisions. Phosphorylation of 
YAP (and TAZ) by the Ser/Thr kinases LATS1/2 regulates subcellular localization of YAP 
and thereby the activation of its downstream targets (Zhao et al., 2008). In the embryo, 
phosphorylation of YAP results in cytoplasmic accumulation, leading to inactive TEAD4 
(Figure 4B). It has been shown that phosphorylated YAP is increased in apolar cells or 
cells with smaller apical domains (Anani et al., 2014). Cells expressing high levels of 
phosphorylated YAP locate in the inside and form the ICM cells. However, in polarized 
cells YAP is not retained in the cytoplasm; instead it shuttles to the nucleus, binds to 
TEAD4 and induces Cdx2 expression. In this way, YAP activation leads to the acquisition 
of a TE fate (Cockburn et al., 2013; Nishioka et al., 2009). 
Importantly, the subcellular distribution of Hippo components constitutes a direct link 
between polarization and fate. It has been shown that the vertebrate-specific Hippo 
pathway component Angiomotin (Amot) is localized to the apical domain of outer cells 
and bound to actin where it is inactive, because it is sequestered by components of the 
polarity pathway. In contrast, in inner cells, Amot is found throughout the membrane, 
co-localized with adherens junctions from where it can mediate YAP phosphorylation 
together with LATS2 (Hirate et al., 2013). Similarly, LATS2 is apically localized in outside 
cells but evenly distributed throughout the cytoplasm of inside cells, suggesting that 
this protein is also sequestered, like Amot, by components of the polarity pathway. 
Additionally, the upstream effector of the Hippo pathway Nf2/Merlin has been shown 
to be required for Lats1/2-dependent YAP phosphorylation in inner cells (Figure 5). This 
mechanism is essential for ICM specification, since its absence leads to TE-markers 
being expressed in inner cells at the expense of ICM-markers irrespective of cell 
position (Cockburn et al., 2013). 
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Figure 5. Differential distribution of Hippo pathway components in the 
first lineage choice. 
Outside cells of the morula contain Amot and Lats2 sequestered in the apical domain 
(blue). This impedes their association and inhibits Amot phosphorylation, thus allowing 
YAP shuffling in the nucleus to activate, together with TEAD4, Cdx2 and TE genes. In 
inside cells, Amot and Lats2 associate in the adherens junctions (AJ, green borders) 
where Nf2 is also present. Lats2 can phosphorylate Amot, and subsequently this 
complex phosphorylates YAP, sequestering it in the cytoplasm. In this way, the Hippo 
pathway is activated, resulting in an ICM fate.  
In this way, the Hippo pathway converts morphological cues into a genetic response 
during the first lineage choice. Also, it has a fundamental role in switching off the 
expression of TE markers such as Cdx2 in the inside population. However, the early 
stochastic expression of lineage specific factors operates when YAP expression is still 
ubiquitously nuclear (Figure 4), suggesting that there might be other mechanisms that 
regulate early expression of TE markers. 
5. Deconstructing transcriptional circuits in the preimplantation embryo. 
The zygotic genome contains all the DNA necessary to specify all the cell types in the 
adult. Non-coding DNA sequences contain the regulatory information relevant for the 
expression of a given gene. Regulation of transcription involves at least two primary 
cis-acting DNA sequence components: promoters and enhancers. Promoters determine 
where transcription begins; they function upstream and proximal to the initiation site 
and must contain at least the minimal sequences responsible for the assembly of the 
basal transcriptional machinery in any cell. In contrast, enhancers play an essential role 
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in driving cell-type specific gene expression; they consist of clusters of sequence-
specific transcription factor binding sites that activate transcription of target genes 
irrespective of their distal position, ranging from several to hundreds or even thousands 
of kilobases (Calo and Wysocka, 2013). Whereas promoters tend to be positioned near 
the transcription start site, the identification of enhancers is more challenging as they 
can be positioned virtually anywhere in the genome and are not distinguished by any 
defining sequence feature. 
The identification of regulatory sequences allows the use of the enhancer sequence to 
drive specific expression of proteins to tissues of interest (for example in Cre -loxP 
systems), permits their deletion to investigate in which molecular mechanisms each 
sequence is involved, and enables identification of the transcription factors that act 
directly upstream of the gene of interest. In the preimplantation embryo, the 
transcriptional circuitry involved in the first lineage choice has been extensively studied 
but the specific regulation of key transcription factors has not been comprehensively 
addressed. Although Oct4, Nanog and Sox2 enhancers have been described, most of 
these studies have been performed in ES cells and there is scant evidence regarding 
their function in early embryos (Catena et al., 2004; Jiang et al., 2008; Levasseur et al., 
2008; Tomioka et al., 2002). 
Recently, the advent of massive parallel sequencing coupled to chromatin 
immunoprecipitation (ChIP-Seq) has increased the predictive capability to detect 
enhancer sequences. The first genome-wide approaches that characterized enhancer 
elements were the identification of specific histone modifications in non-coding 
regulatory sequences as indicators of transcriptional activity and ChIP-Seq of the 
enhancer-associated protein p300 (Heintzman et al., 2007; Rada-Iglesias et al., 2011; 
Visel et al., 2009). Today, the Encyclopedia of DNA Elements (ENCODE) project provides 
a comprehensive list of functional elements in the mouse and human genome, 
including regulatory elements that control cells and tissues in which a gene is active 
and elements that act at the protein and RNA levels (Stamatoyannopoulos et al., 2012), 
thus facilitating the identification of putative regulatory sequences. Enhancers are 
associated with transcription factors and thereby associate with regions of nuleosomal 
depletion; in this way, enhancers exhibit high sensitivity to DNA nucleases such as 
DNase I. Also, histones surrounding enhancer regions are enriched for H3K4me1 and 
H3K27ac (Creyghton et al.; Heintzman et al., 2009; Rada-Iglesias et al., 2011). 
Nevertheless, while highly valuable, these data provide only indirect evidence of cis-
regulatory activity. In addition to this, large-scale epigenomic mapping of non-coding 
regulatory regions in preimplantation embryos is not feasible with current techniques. 
The amount of material we can retrieve compared with the quantity of chromatin that is 
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routinely used in this type of experiment is very limited. Thus, we still need to 
understand the regulatory mechanisms that underlie the variable expression of core 
transcription factors. It is also important to define which elements are critical for their 
functionality. Since Cdx2 is a key factor for TE specification and is the first factor to be 
differentially expressed, we focus our study on Cdx2 regulation. To overcome the 
technical limitations of working with preimplantation embryos, stem cell populations 
derived from the blastocyst can serve as a complementary tool for investigation of the 
regulatory mechanisms and networks involved in the first lineage choice during 
mammalian development. 
6. Embryo derived stem cell populations. 
An important property of the mouse blastocyst is that TE and ICM populations can be 
isolated and cultured in vitro under conditions of stemness and also can be directed to 
differentiate, thereby providing additional tools for studying the gene regulatory and 
signalling networks operating in development. 
In the early 80s, mouse embryonic stem cells (ES) were derived from the epiblast and 
pluripotency was captured in culture (Evans and Kaufman, 1981). Additionally, 
trophoblast stem cells (TS cells) have been derived from the trophectoderm lineage 
(Tanaka et al., 1998), and extraembryonic endoderm (XEN) cells from the primitive 
endoderm (Kunath et al., 2005). Like other stem cells, these cells can either self-renew 
or differentiate into lineage-specific cell types. Importantly, all have been shown to 
contribute mainly to their lineage of origin in chimaeras (Beddington and Robertson, 
1989; Kunath et al., 2005; Tanaka et al., 1998). ES cells can be injected into a host 
blastocyst and this yields chimaeric mice with ES cell contribution to all tissues of the 
adult organism, including functional colonization of the germline. Moreover, using 
embryo aggregation with tetraploid hosts, it is also possible to derive live-born mice 
entirely composed of ES cell derivatives. ES cells thus show an unprecedented 
developmental capacity after prolonged in vitro culture. In a similar fashion, when TS 
cells are injected into a host embryo, they colonize and contribute to the TE and the 
placenta. Results obtained from the analysis of mouse mutants suggest that ES and TS 
cells recapitulate the lineages from which they originate. ES cells express Oct4 and 
cannot be derived from Oct4 mutant embryos, suggesting they parallel the ICM 
(Nichols et al., 1998); analogously, no TS cells can be derived from Cdx2 mutant 
embryos (Strumpf et al., 2005), implicating Cdx2 as a main transcription factor in TS 
regulation and suggesting that TS cells resemble the TE. 
ES cells can be derived solely from preimplantation stages since epiblast-derived cells 
from the post-implantation embryo, although they share some features, do not 
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contribute to chimaeras (Rossant, 2008; Tesar et al., 2007). Importantly, ES cells closely 
resemble the epiblast of the blastocyst, when the primitive endoderm has already 
segregated (Boroviak et al., 2014). In contrast, TS cells can be derived from blastocysts 
as well as from the extraembryonic ectoderm (ExE) up to 8.5 dpc of the post-
implantation embryo (Tanaka et al., 1998). Additionally, the similarity of TS cells to 
either ExE or TE has not yet been assessed. A defined culture medium for TS cells has 
been developed only this year (Kubaczka et al., 2014). RNA profiling in TS cells derived 
at different developmental stages (TS3.5 or TS6.5) to compare the effect of culture media 
showed that TS clustered together according to their developmental stage. However, 
future work is needed to characterize different possible populations within TS cells. 
Stem cells allow a detailed molecular study of the interactions between components of 
the regulatory circuitry. Manipulation in ES cells of key components can help us to 
better understand the first lineage choice. It has been shown that some modulation 
over core factors causes stem cell lines to adopt properties of other lineages despite 
the lineage restriction between ICM/ES and TE/TS. ES cells with downregulated Oct4 or 
overexpressing Cdx2 can grow as TS-like cells in the presence of TS growth medium. 
Moreover, Cdx2-overexpressing cells have been shown to contribute to the placental 
lineage in chimaeras (Niwa et al., 2000; Niwa et al., 2005). This conversion from ES to TS 
is seen in ES cells overexpressing Gata3, Ras or Tead4 (Lu et al., 2008; Nishioka et al., 
2009; Ralston et al., 2010). Manipulation of these factors not only changes fate. It has 
also been shown that under certain culture conditions, ES cells revert to a totipotent 
state and contribute in vivo to both embryonic and extraembryonic lineages (Macfarlan 
et al., 2012; Morgani et al., 2013). Additionally, following reprogramming of iPS cells in 
vivo, cells acquire a totipotent-like state displaying both ES and TS cell features: in vivo 
iPS cells can contribute to the TE and the placenta when injected in host embryos 
(Abad et al., 2013). 
Stem cell lines from the first three lineages of the mouse blastocyst have not only 
provided an invaluable tool to understand the first lineage choice, but ES cells have also 
emerged as a research model in their own right. Their ability to self-renew and retain 
the capacity to differentiate into any adult tissue provides the perfect framework within 
which to understand differentiation into any cell fate, to build organs in vitro or to 
model diseases. 
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7. The Notch pathway and the control of cell fate. 
Notch is one of the key signalling pathways during embryonic development. It 
functions as a general developmental tool that is used to direct cell fate and, 
consequently, to build an organism. Notch signalling controls cell fates through local 
cell interactions and is involved in processes such as stem cell pool maintenance, cell-
cell interactions and epithelial-to-mesenchymal transitions (Liu et al., 2010; Perdigoto 
and Bardin, 2013). The implementation of a particular developmental program 
modulated by Notch depends on how Notch integrates its activity with other cellular 
factors. 
Figure 6. Core 
components in the 
Notch signalling 
pathway. 
In the signalling cell, 
membrane-bound Notch 
ligands (Dll1, 3, 4 and Jag1, 2, 
in pink) interact with the 
Notch receptor (Notch1-4) in 
the adjacent cell. Ligand-
receptor interaction leads to 
Notch receptor processing by 
the γ-secretase, which releases 
the Notch intracellular domain (NICD) in the receiving cell. NICD translocates to the 
nucleus and forms a transcriptional activation complex after binding to RBPJ. This ternary 
complex directs the transcription of a set of target genes. 
In mammals, the core components of this pathway include four Notch transmembrane 
receptors (Notch1-4), their canonical membrane-bound ligands of the Delta-like (Dll1, 
Dll3, Dll4) and the Jagged family (Jag1 and Jag2), and specific co-factors such as 
Mastermind (Maml 1-3). Notch ligand and receptor interaction induces a cascade of 
proteolytic events, which involves ADAM metalloproteases and the γ-secretase 
complex. The γ-secretase minimally consists of four individual proteins: presenilin, 
nicastrin, APH-1, and PEN-2. It cleaves Notch receptor inside the receiving cell. Notch 
cleavage leads to the release of the intracellular domain of the Notch receptor (NICD), 
which then translocates to the nucleus to mediate gene activation. Notch activation 
results in the displacement of RBPJ repressors (such as N-CoR). The NICD binds the 
transcription factor RBPJ and after the recruitment of the co-activator MAML leads to 
transcriptional activation of target genes (Artavanis-Tsakonas and Muskavitch, 2010) 
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(Figure 6). Common targets of the pathway are the Hes and Hey families of 
transcription factors and MYC (Ntziachristos et al., 2014). 
Notch-ligand interaction normally occurs between two neighbouring cells (Figure 6), 
where the signalling cell interacts through its ligands with the Notch receiving cell. 
Nonetheless, ligand-receptor interaction drives multiple outputs (Figure 7). 
Additionally, Delta and Notch expression in different systems indicates that individual 
cells can express receptor and ligand at the same time and that they can interact even if 
they are in the same cell, to induce cell-autonomous effects on Notch dependent 
signals. Furthermore, depending on the expression level, their action can be either 
agonistic or antagonistic (Artavanis-Tsakonas and Muskavitch, 2010). 
Loss of Notch function in vertebrate development has been shown to disrupt aspects of 
neurogenesis, heart development, somite formation, angiogenesis, and lymphoid 
development (Andersson et al., 2011). Analysis of mutants has shown that a number of 
them die from 9.5 dpc -11.5 dpc and interestingly, the analysis of mouse strains with 
targeted mutations in the Notch2, Notch1/4, Hey1/2, Dll4 and Rbpj genes has 
demonstrated that these genes are indispensable for proper development of the 
placenta, a TE derived tissue (Gasperowicz and Otto, 2008). Although mutants for Notch 
receptors and ligands do not show any preimplantation phenotype, there are two 
reports of Notch pathway components presenting preimplantation defects. Brainiac is a 
glycosyltransferase that shares some features with Fringe (Goode and Perrimon, 1997). 
It modifies Notch receptors on the extracellular domain by adding glucosides and this 
modulates Notch-Dll interactions. Brainiac null embryos die between 3.5 dpc and 4.5 
dpc. Initially the null embryos appear morphologically indistinguishable from wild-type 
littermates and hatch properly, but they die after 48h in culture (Vollrath et al., 2001). 
Notchless (Nle) is another modulator of the Notch signalling pathway activity, and 
disruption of Nle results in embryonic lethality shortly after implantation due to an 
increase in apoptosis of the ICM (Cormier et al., 2006). Importantly, Nle is expressed 
specifically in the ICM and Nle mutant embryos show normal CDX2 expression. 
However, the specific role of Brainiac and Nle in the Notch pathway has not been 
described in detail yet.  
Therefore, the control of cell fate during the first lineage choice relies on different 
regulatory mechanisms that act in combination to ensure embryo development. To 
better understand the TE/ICM specification process, it is crucial to link the expression of 
transcription factors with inputs from different signalling pathways. 
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Figure 7. Notch mechanisms in development and differentiation. 
The Notch pathway has different roles in binary cell fate decisions. (A) Lateral inhibition. 
(Left) Within a group of cells of the same type which expresses equal amounts of ligand 
and receptors, a single cell varies its ligand levels. (Right) The ligand then activates the 
Notch signalling cascade in the neighbouring cell, thereby promoting two different fates. 
(B) Lateral induction. The Notch pathway expression of ligand and receptors in all cells 
favours a homogenous expression of the signalling pathway and target gene expression. 
(C) A cell type induces stem cell proliferation without differentiation. (D) A Notch 
expressing cell initiates differentiation. 
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OBJECTIVES    
The detection of regulatory elements that drive the expression of core transcription 
factors can shed light on the regulatory mechanisms that confer stochastic expression 
and lineage commitment of these factors during the first lineage choice. A Cdx2 
enhancer previously characterized in the lab directs reporter expression to the TE, 
opening the possibility to dissect specific Cdx2 regulation. With this aim in mind, we 
defined the following objectives: 
» Identify the minimal sequence that directs TE-specific enhancer activity. 
» Study the behaviour of the identified element in vivo. 
» Find the regulatory inputs that direct enhancer activity identified upstream of 
Cdx2. 
» Characterize these inputs in relation to endogenous Cdx2 expression and TE 
specification. 
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“If you want to inspire confidence, give plenty of statistics 
 – it does not matter that they should be accurate, or even intelligible, so long as 
there is enough of them.” 
Three Months in a Curatorship. LEWIS CARROLL. 
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MATERIALS & METHODS    
1. Construct generation for microinjection 
Cdx2 genomic regions were amplified by PCR using BAC RP245I065 as template. This 
BAC covers the whole intergenic region containing mouse Cdx2 and was obtained from 
the BACPAC Resources Center (http://bacpac.chori.org/). The restriction enzyme 
strategy or primers used for PCR, together with the lengths of corresponding amplified 
fragments (Figure 9), were as follows: 
Table 1. Primers used for fragment amplification and cloning 
Fragment Primer F Primer R Product 
size (bp) 
#1 GTTTGGAGAGAAGAAAGGAG GGGTGAAGTGAAGAAGATCAG 5428 
#2 Short piece of Fragment #1 digested with ApaI 1856 
#3 Long piece of Fragment #1 digested with ApaI 3572 
#4 TGCTAACACAAGCTCCCTCA AAAGCAGGGAAGAGCACTTTA 766 
#5 GACTGGCTGCCTTACCAGAG TCTTCCAAAGACGCTGGAGT 1487 
#6 CACACGGATGAATTGTCTGG AACAGGGACAGGTGAGATGG 1329 
#7 GCCTAGGATGCTGACTGAGG CCCAAGTTGGAAAGGTTTGA 809 
#8 ATCTCACCTGTCCCTGTTGG CCCTGGGTGAAGTGAAGAAG 1107 
 
As a positive control, we used the Pou5f1 distal enhancer element (Oct4DE, Figure 10) 
(Pernaute et al., 2010; Yeom et al., 1996). Each fragment was subcloned in pGEM-T Easy 
Vector and then excised and cloned into a modified pBluescript vector (Yee and Rigby, 
1993) containing either a lacZ reporter gene or H2BmRFP reporter gene under the 
control of the human beta-globin minimal promoter and including an SV40 
polyadenylation signal. Constructs were linearized and plasmid sequences removed 
before microinjection. 
2. Transient transgenic analysis 
For the generation of transient transgenic embryos, F1 (C57Bl/6xCBA) females were 
superovulated to obtain fertilized oocytes as described (Nagy, 2003). Each construct 
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was microinjected at 3-6 ng/μl into the pronucleus of fertilized oocytes at 0.5 dpc. 
Microinjected oocytes were cultured in microdrops of M16 medium (Sigma) covered 
with mineral oil (Sigma) at 37°C, 5% CO2 until the blastocyst stage. 
A minimum of 50 blastocysts were used to calculate the percentage of lacZ or 
H2BmRFP positive embryos per construct. When using the empty vector containing 
only the minimal promoter and the different reporter as a negative control, we 
routinely obtain low-level punctuate lacZ expression or weak H2BmRFP expression in 
approximately 10% of blastocysts. For lacZ staining, blastocysts were fixed in buffer 
containing 1% formaldehyde, 0.2% glutaraldehyde, 2 mM MgCl2, 5 mM 
ethyleneglycoltetraacetic acid (EGTA), and 0.02% Igepal for 5 min at room temperature. 
After 2x 5min washes in phosphate buffered saline (PBS), blastocysts were transferred 
to X-Gal staining solution for 24 hours at room temperature in the dark. For H2BmRFP 
detection, embryos were fixed in 4% paraformaldehyde for 10 min at room 
temperature and either analysed for endogenous fluorescence or processed for 
immunostaining. To visualize nuclei, embryos were incubated in DAPI at 1µg/ml (Vector 
Laboratories). 
3. Generation of TEE mouse lines 
Three independent transgenic mouse lines where obtained for fragment #3 constructs 
linked to each lacZ or H2BmRFP. All lines reproduced the TE-restricted expression 
pattern in early pre-implantation stages. Genotyping was performed by PCR using SV40 
and 5’-rev comp primers for the lacZ-TEE lines, and 5'Cdx2 and mRFP primers for the 
mRFP-TEE lines. Primer sequences are indicated in the table below: 
Table 2. Primers used for genotyping 
Primer Sequence Product size (bp) 
SV40 TCACTGCATTCTAGTTGTGG 
150 
5’-rev comp CTGATCTTCTTCACTTCACCCAG 
5'Cdx2 GCAGGTGGCTGATCTTCTTC 
900 
mRFP GAGCCGTACTGGAACTGAGG 
 
PCR conditions were 95ºC for 5min, 35 cycles of 94 ºC for 1min, 60ºC for 1min and 
72ºC for 1 min, followed by 72 ºC for 10 min. Embryos were collected from crosses of 
TEE-lacZ or TEE-mRFP males with outbred superovulated ICR females. 
Embryo handling and mouse strains
 
27 
4. Mouse breeding 
The different mouse lines used are listed in the table below: 
Table 3. Mouse strains. 
Alleles Reference 
Cdx2 -/- (Strumpf et al., 2005) 
Tead4 -/- (Nishioka et al., 2008) 
Rbpj -/- (Oka et al., 1995) 
RosaNotch (Murtaugh et al., 2003) 
RosaYFP (Srinivas et al., 2001) 
Sox2 Cre (Hayashi et al., 2002) 
 
Adults were genotyped by PCR of tail-tip DNA using primers and conditions previously 
described for each line. For preimplantation embryos, genotyping was performed 
directly on individually isolated embryos, after observation in culture and X-gal or 
antibody staining. 
Animal procedures were approved by the CNIC Animal Experimentation. 
5. Embryo collection and culture 
For characterization of lacZ-TEE and mRFP-TEE mouse lines, 0.5 DPC embryos were 
collected from swollen ampulas, treated with hyaluronidase (Sigma) to remove cumulus 
cells and cultured until the blastocyst stage at 37.5°C in 5% CO2 in air, in M16 medium 
(Sigma) covered with mineral oil (Sigma). For experiments using Tead4, Cdx2 and Rbpj 
mutant mouse strains, 2.5 dpc embryos were collected by flushing the oviduct through 
the infundibulum, and were cultured up to the blastocyst stage. For experiments with 
RosaYFP and RosaNotch strains, 3.5 dpc embryos were recovered by flushing uteri with M2 
media (Sigma). 
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6. Mutagenesis 
Mutated versions of fragment #6 (TEERBPJmut, TEETEADmut and TEERBPJ/TEADmut) were 
generated by site-directed mutagenesis (Mutagenex Inc.). RBPJ binding sites were 
located according to the consensus motif and changes that abolish binding were 
introduced as described (Tun et al., 1994). TEAD binding sites were based on the MCAT 
consensus motif (5′-CATTCCA/T-3′) (Anbanandam et al., 2006). The following changes 
were introduced: 
Table 4. Substitutions introduced in RBPJ and TEAD binding sites. 
Lower case indicates the altered residues. 
RBPJ binding sites mm9 assembly position Mut 
TTCCCACCG chr5:148124480-148124488 TTCggACCG 
TGTGGGAAA chr5:148124694-148124702 TGTccGAAA 
TTCCCAGGT chr5:148124759-148124767 TTCggAGGT 
TTCCCACTT chr5:148125418-148125426 TTaggACTT 
 
TEAD binding sites mm9 assembly position Mut 
AATTCCTA chr5:148124456-148124465 AcggaaTA 
ATTCCAG chr5:148125498-148125504 cggaaAG 
 
7. Pharmacological inhibitor treatments 
Two-cell embryos were cultured in drops of M16 medium containing the corresponding 
pharmacological inhibitor or control (DMSO) until the blastocyst stage. The following 
inhibitors and concentrations were used: 10 μM of the γ-secretase inhibitor RO4929097 
(S1575, Selleckchem) (Munch et al., 2013) and 2.5 μM of the TEAD/YAP inhibitor 
Verteporfin (Sigma) (Liu-Chittenden et al., 2012). 
8. Cell culture 
Mouse embryonic fibroblasts were grown in standard media conditions and mitomycin 
inactivated as described (Himeno et al., 2008) to obtain mitomycin-treated primary 
embryonic fibroblast conditioned media (EMFI-CM) for TS cell culture. 
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The B1-TS cell line was established and maintained as described (Tanaka et al., 1998). 
TS cell lines were derived from lacZ-TEE or mRFP-TEE mouse strains (see below, section 
13). 
ZHBTc4 ES cells were cultured on gelatin-coated dishes with 1000 U/μl LIF (ESGRO-LIF; 
Millipore) (Niwa et al., 2005). Repression of Oct4 (official name Pou5f1) in ZHBtc4 ES 
cells was induced by addition of tetracycline (Sigma) at 1µg/ml in EMFI-CM media 
(Tanaka et al., 1998) in the presence of 2.5x10-3µg/ml FGF4 (R&D Systems) and 1µg/ml 
heparin (Sigma). 
5TVER7-ES cells were cultured on gelatin-coated dishes with 1000U/μl LIF as previously 
described (Nishioka et al., 2009). Tead4VP16ER was induced by incubation of cells for 
48 h with 4-hydroxytamoxifen (Sigma) at 0.1μg/ml in EMFI-CM media in the presence 
of 2.5x10-3µg/ml FGF4 and 1µg/ml heparin.  
9. Immunohistochemistry  
Immunohistochemistry was performed as previously described (Dietrich and Hiiragi, 
2007). Cells were cultured on gelatin-coated glass coverslips and fixed in PBS with 4% 
paraformaldehyde. Samples were permeabilised and blocked at room temperature 
before incubation. The following antibodies and dilutions were used: monoclonal 
mouse anti-CDX2 (MU392-UC, BioGenex) 1:200, rabbit polyclonal living colours DsRed 
(632496 Clontech) 1:500, monoclonal mouse anti-OCT4 (sc-5279, Santa Cruz) 1:200, 
rabbit polyclonal living colours GFP (632460 Clontech) 1:200, mouse anti-TEAD4 
(ab58310 Abcam) 1:100, and rabbit anti-Cleaved NOTCH1 (Val1744) (2421, Cell 
Signalling Technology) 1:100. Nuclei were visualized by incubating embryos in DAPI at 
1µg/ml and Rhodamin-phalloidin (Molecular Probes) 1:300, to detect F-actin in the cell 
membrane. 
10. Quantitative-PCR 
RNA was isolated from ZHBTc4 and 5TVER7 cells with the RNeasy Mini Kit (Qiagen) and 
then reverse transcribed using the High Capacity cDNA Reverse Transcription Kit 
(Applied Biosystems). For γ-secretase inhibitor experiments, RNA from pools of 25 
embryos was isolated using the Arcturus PicoPure RNA Isolation Kit (Applied 
Biosystems) and reverse transcribed using the Quantitect Kit (Qiagen). cDNA was used 
for quantitative-PCR (qPCR) with Power SYBR® Green (Applied Biosystems) in a 7900HT 
Fast Real-Time PCR System (Applied Biosystems). Expression of each gene was 
normalized to the expression of the housekeeping genes Actin and Ywhaz 
(Vandesompele et al., 2002). The following primers were used: 
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Table 5. qPCR primers  
Gene Forward Primer Reverse Primer 
Actin CAGAAGGAGATTACTGCTCTGGCT TACTCCTGCTTGCTGATCCACAT 
Cdx2 TCAACCTCGCCACAACCTTCCC TGGCTCAGCCTGGGATTGCT 
Eomes TTCACCTTCTCAGAGACACAGTTCAT GAGTTAACCTGTCATTTTCTGAAGCC 
Esrrb GGACACACTGCTTTGAAGCA ACAGATGTCTCTCATCTGGC 
Fgfr2 GAGGAATACTTGGATCTACC CTGGTGCTGTCCTGTTTGGG 
Gata3 GGGTTCGGATGTAAGTCGAG CCACAGTGGGGTAGAGGTTG 
Hand1 TGCACAAGCAGGTGACCCCG CCCTTTAATCCTCTTCTCGCCG 
Nanog CTTACAAGGGTCTGCTACTGAGATGC TGCTTCCTGGCAAGGACCTT 
Oct4 ATCAGCTTGGGCTAGAGAAGGATG AAAGGTGTCCCTGTAGCCTCATAC 
Stra13 GGTGAGCAGACTACTCCATTT GTGCCCCACATATTCCCCAC 
Ywhaz CGTTGTAGGAGCCCGTAGGTCAT TCTGGTTGCGAAGCATTGGG 
 
11. Cell transfections 
Transfection of TS cells was performed with Lipofectamine 2000 (Invitrogen) and 2.5µg 
DNA in non-adherent dishes following the manufacturer’s instructions. ZHBTc4 cells 
were transfected in 6 well plates with Lipofectamine 2000 and 0.8µg DNA (eGFP, empty 
vector, Oct4DE or fragments I, II or III). At 6h after transfection, media was changed and 
tetracycline added when indicated. 5TVER7 cells were transfected similarly; cells were 
transfected in 12 well plates with 0.4µg DNA (eGFP, empty vector, Oct4DE or fragments 
I, II or III).  
Forty-eight hours after transfection, cultures were measured by flow cytometry 
(LSRFortessa Flow Cytometer) or random fields per well were photographed (Zeiss) and 
fluorescent cells counted (ImageJ). Regulatory activity is expressed as the proportion of 
red (RFP+) over total control green (GFP+) cells transfected. 
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12. Histone ChIP 
Histone ChIP on cross-linked chromatin from TS cells followed by quantitative PCR 
(qPCR) was carried out as previously described (Azuara, 2006). Briefly, 50µg of 
precleared cross-linked chromatin was incubated overnight with 5µg of the antibody 
followed by 4h incubation with Sepharose A beads. Elutes were digested with 
Proteinase K (0.5mg/ml) and Rnase A (0.1mg/ml) and DNA was phenol-choloroform 
extracted and recovered by standard precipitation with ethanol. The following 
antibodies were used: anti-H3K4me1 (ab8895; Abcam), anti-H3K4me3 (ab8580; Abcam), 
anti-H3K27me3 (07-449; Millipore), anti-H3K27ac (ab4729, Abcam), anti IgG (m7023, 
Sigma). Table 6 lists primers used for ChIP. ChIP data are represented as fractional 
differences (difference between the enrichment of the histone mark minus the IgG 
basal enrichment divided by the IgG value for the specific primer sets). 
Table 6. Primers used for ChIP experiments 
 
Fragment Primer Forward Reverse 
Actin CCCCAACACACCTAGCAAAT ACTGCCCCATTCAATGTCTC 
Nanog CCCAGGTTTCCCAATGTGAAG AAAGAGTCAGACCTTGCTGCCA 
Sox1 ACAAGAGGAGGCAGCGAACC TCGCAGGTGGAAAGTTTCTCC 
I 
1 TCCTGGGAGATGTCGGGTGCC CAGCTCTGGGTTCAGGCCGC 
2 CTGCCTGCCTCCTCCCTCCA GGGCCCCCTCTGCCTACACT 
II 
3 GGAACGCGTCTCACCTGCCC CCAGCAGCCCCGCGCTATTT 
4 CCCGCGCCTGCTTTGGAAGT GCCAGCGCGTGGTGCTCTAA 
5 CACTCCGGCAGCATTGCCCA TGGCACAGCCAGGCCACATG 
promoter promoter CTCGACGTCTCCAGCCATTGGT CCAGCGGCCTTACGTGATTAAC 
intergenic 
6 GGTGGCTTGTAGAGCTGCGGT GGGGGCGCAACCTGGAGGTA 
7 CCCAATCTCATCAAGCTGCCTTTG TGGAACCCTACAGGAGAACCTTTG 
III 
8 AGGTTCTCCACTTGCTGCGGC GCATCCAAGCACGGAAGTGAACA 
9 GCCCCATTCACAGTCTCCAGTTACA TGCTTCGTTCCTCACCTTCCCCA 
10 TCCCACCGAACGCAAAACAGCT ACCGCTCCTGTGGCCCAGAA 
11 CTCGGAGGGATAAGCTCTCAAGTGT TGCCTCTCTGGAACAACCCGGT 
12 AGGGCTGGCATCCTCGAGCA TGTGCCACAGCTTTTGGGCT 
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13. TS cell derivation 
TS cells were derived essentially as described. (Himeno et al., 2008; Tanaka et al., 1998). 
3.5 dpc blastocysts were obtained from wt superovulated females. For the derivation 
TSL cells, females were mated with lacZ-TEE heterozygote males. TSR cells were derived 
from homozygote mRFP-TEE x wt crosses. 
Blastocysts were plated in 4 well plates of 5x104 inactive mouse embryonic fibroblasts 
(EMFIs) with EMFI-CM media supplemented with 37.5x10-3µg/ml FGF4 and 1.5µg/ml 
heparin. Plated blastocysts hatch, adhere to the well and form outgrowths in the dish. 
Depending on the individual blastocyst, outgrowths were tripsinized from days 4 to 6 
and subsequently plated until TS cell colonies were clearly visible. After 20-21 days, 
MEFs were removed and TS-derived cells were cultured in EMFI-TS media on plastic 
dishes. 
Twelve independent clones (TSL) were derived from the lacZ-TEE line and 7 TS clones 
(TSR) from the TEE-mRFP mouse line. Four TSL and two TSR clones were selected for 
further characterization. 
 TSL cells genotyping  13.1
Genomic DNA was extracted by digestion in a 4well plate with 500ul of embryo lysis 
buffer with Proteinase K (0.1mg/ml) overnight at 55ºC. DNA was phenol-choloroform 
extracted and recovered by standard precipitation with ethanol. In order to detect the 
presence of the transgene in TSL clones, PCR was performed with the SV40 and Cdx2-
rev comp. primers (Table 2). Three (TSL #1- #3) out of 4 clones were PCR amplified for 
the transgene. 
 TSR and TSL cell expression profile 13.2
TSL and TSR cells formed epithelial colonies as expected and were capable to self-renew 
and differentiate appropriately upon removal of FGF4 and heparin (Figure 8A). The TSL 
and TSR cells were further characterized by qPCR expression profiling (view section 10). 
TSL and TSR derived lines expressed Cdx2, Eomes, Esrrb and Fgfr2, factors involved in 
the TS pluripotency network and showed differentiation markers (Stra13, Hand1) to the 
same extent as TS. From the analysis, we selected TSL #2 and TSR #1 for further study. 
 TS derived cell cycle profiling 13.3
TS cells have the potency to differentiate into various cell types, the most readily 
detectable being the differentiation to trophoblast giant cells. Giant cells are formed by 
endoreduplication of DNA content. A cell cycle profiling assay was performed to 
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evaluate the capacity of the selected clones to differentiate in normal TS culture 
conditions and upon FGF4 removal. 
Cell cycle was profiled by flow cytometry using a LSRFortessa Flow Cytometer (Tanaka 
et al., 1998). Briefly, tripsinized cells were fixed in 70% ethanol, treated with RNAse at a 
final concentration of 100μg/ml, and resuspended in 0.003% propidium iodide solution. 
DNA content profiles of TS cells (2n/G1 phase), replicating TS cells (up to 4n/S-G2-M) 
and endoreduplicating cells (4n or >4n) are shown in Figure 8E-G. For the different 
clones analysed (2 TSL clones and 1 TSR clone), ~ 20-30% of cells differentiated in 
normal culture conditions, whereas after 6 days of differentiation, the percentage 
increased up to 42%. Some giant cells might not have been included in the flow 
citometry due to their size thus not being able to detect all the differentiated cells. 
 
Figure 8. Characterization of TSL and TSR cells. 
(A) Representative TSL epithelial colony in early passages. (B) TSL clone upon FGF4 removal 
subjected to differentiation. Arrowheads point to differentiated cells. Relative expression 
of (C) TS pluripotency and (D) differentiation markers in TSL (#0-#3) and TSR (#1- #2) 
clones. TSL #0 was genotyped as lacZ negative. (E-G) DNA content in different TSL and TSR 
cells. DNA content is represented by the propidium iodide intensity. 
14. TS cell infection 
Lentivirus encoding the GFP reporter were generated by transient transfection of 293T 
cells. For transduction, 106 TS cells were seeded in suspension followed by adding 0.25 
mL vector suspension in RPMI media (1×108IU/mL, MOI = 100). Eight hours post 
infection, vector suspension was removed and transduced cells were seeded in a 24 
well dish with fresh EMFI-CM TS media and incubated at 37°C with 5% CO2. 
Transduction efficiencies were evaluated 48h post-infection. 
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15. TS cell injection 
Eight to 10 TSR cells were microinjected into eight-cell stage embryos using standard 
techniques (Springer, 2011). Morulae were incubated overnight in M16 medium (Sigma) 
microdrops under mineral oil. Endogenous fluorescence was assessed the next day. 
Immunohistochemistry for CDX2 and mRFP1 was performed when indicated as in 
section 9. 
16. Imaging and quantification 
Images of transfected cells were acquired with a Zeiss Axiover 200M inverted 
microscope. Confocal images of cells were acquired with a Leica SpE microscope (20x 
or 40x objective). Confocal images of microinjected or antibody-stained embryos were 
acquired with a Leica SP5 confocal microscope. Images were acquired with a 63x 
objective and 2x zoom every 2.5μm. Images of lacZ-stained embryos were obtained 
with a Leica DMIRE2 inverted microscope. Images were prepared for figures using 
Adobe Photoshop CS5. 
For quantification, unmodified images were analysed as previously described using 
IMARIS imaging software version 7.6.3 (Bitplane AG) (Dietrich and Hiiragi, 2007) 
(Dietrich and Hiiragi, 2007) with some modifications. Nuclei were segmented in 3D 
reconstructions based on DAPI staining with an 8μm isosurface. After computer 
segmentation, segments were inspected visually and corrected when necessary. The 
number of nuclei staining positive for TEE, CDX2 or GFP was evaluated visually (8-cell 
stage embryos) or by segmentation (IMARIS software; 2.5 dpc to 4.5 dpc). CDX2 protein 
level was estimated from unmodified mean fluorescence intensities within segmented 
nuclei. Mean DAPI fluorescence intensity was used to minimize error caused by staining 
and confocal imaging variability. CDX2 intensity values for each blastomere were 
normalized to the mean DAPI fluorescence intensity for each nucleus, and these ratios 
were normalized to the average mean DAPI intensity per whole embryo. 
17. Statistics 
Statistical analyses were performed with GraphPad Prism 5. Data are presented as 
means ± s.e.m or ± s.d. as indicated in the figures. Differences were considered 
statistically significant at p < 0.05. p values were calculated by t-test for comparisons of 
two groups, and ANOVA with Bonferroni post-test for multiple pair wise comparisons. 
For the data presented in Figure 24, Figure 27 and Figure 33, a Chi square test was 
performed. 
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B1-TS, 5TVER7 ES cell culture assays and RO treatments of wild type embryos were 
performed in collaboration with Sergio Menchero. TSL and TSR cell lines derivation and 
characterization, TSR injections, mouse genotyping and ZHBTc4 ES cells transfections 
were performed in collaboration with Inma Ors and the CNIC Transgenesis Unit. 
Histone ChIP was carried out in Veronique Azuaras’ lab at the Institute of Reproductive 
& Developmental Biology, Imperial College London, UK in collaboration with Anne 
Hellness. Vectors were produced, concentrated, and titrated by the CNIC Viral Vectors 
facility. TEE-mRFP line generation and Cdx2 -/- breeding was performed in collaboration 
with Andres Nieto from the lab of Janet Rossant at the Developmental & Stem Cell 
Biology Department in The Hospital for Sick Children, Toronto, Canada. CBF reporter 
was generated and characterized in collaboration with Panagiotis Xenopoulus at Kat 
Hadjantonakis lab at the Sloan-Kettering Institute, New York, USA. 
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 “Sometimes I've believed as many as six impossible things before breakfast.” 
Through the Looking-Glass. LEWIS CARROLL 
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RESULTS    
1. Identification of a trophectoderm-specific Cdx2 enhancer. 
To better understand how the first lineage decision takes place in the mammalian 
embryo, we studied the regulation of Cdx2, one of the first transcription factors 
involved in this process. Cdx2 is the first gene expressed in the TE and is the first 
transcription factor shown to be allocated to the outermost population of the compact 
morula (Dietrich and Hiiragi, 2007; Strumpf et al., 2005). 
Screening of stage-specific functional enhancers in vivo by transient transgenic analysis 
of non-coding DNA sequences has long been used as a tool to evaluate the regulatory 
potential of a given sequence during development. Transient transgenesis in cultured 
blastocysts also allows relatively fast interrogation of enhancer capacity because 
enhancer potential is scored three days after DNA microinjection of the zygote, and 
embryos do not need to be transferred to a foster female to continue their 
development. Using this approach, assessment of transcriptional activity is as 
straightforward as in cell culture assays, but with the advantage that scoring of the cis-
regulatory selected sequence is stage- and tissue-specific. Moreover, the systematic 
and extensive screening of cis-regulatory sequences with this method provides a 
convenient way to narrow down the size of a functional DNA sequence without the 
need to generate stable lines of all the regulatory sequences analysed. 
Previous work in the lab, using transient transgenic analysis in mouse preimplantation 
embryos, identified a cis-regulatory element located 5’ of Cdx2 that drives reporter 
expression in the trophectoderm (TE) of the blastocyst (fragment #1). Unlike other 
elements tested in the vicinity of Cdx2, fragment #1 showed TE-specific activity in 
transient transgenic assays at the blastocyst stage, thus reproducing the endogenous 
Cdx2 expression pattern. Using transient transgenesis, we were able to track reporter 
expression in the ICM driven by the Oct4 distal enhancer (Oct4DE) (Yeom et al., 1996) 
(Figure 10A) and TE-specific activity of fragment #1 (Figure 9), confirming that this 
fragment reproduces the endogenous Cdx2 expression pattern (Figure 10 B,C). 
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Figure 9. A cis-regulatory element upstream of Cdx2 drives restricted 
expression in the trophectoderm. 
Diagram of the Cdx2 locus showing the fragments tested in transient transgenic 
embryos, the specific activity of the fragments in the TE, and the percentage of 
embryos for each construct showing reporter activity. 
We then characterized the minimal DNA fragment able to reproduce the TE-restricted 
expression shown by fragment #1. We first divided the DNA region into two smaller 
regions (fragments #2 and #3) by restriction enzyme digestion with ApaI. Fragment #2 
is a 1.8Kb DNA sequence located in the more proximal region to Cdx2 gene, and 
fragment #3 is the remaining 3.6Kb DNA sequence located 4331 bps upstream of the 
Cdx2 transcription start site. Fragment #3 directed TE-specific reporter expression, while 
fragment #2 was negative for cis-regulatory activity (Figure 9). 
In order to find the minimal DNA region that contains Trophectoderm-specific 
enhancer activity (TEE), we designed smaller overlapping DNA fragments of around 
800-1500bp (fragments #4 to #8) that covered fragment #3 in full (Figure 9). Fragment 
#6 (1329bp) preserved TE restricted expression of the reporter gene (Figure 10C). 
Fragments that drove TE-specific expression pattern were tested with both H2BmRFP 
(data not shown) and LacZ reporters (Figure 10C). 
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Figure 10. Fragments tested by transient transgenesis in the blastocyst. 
H2BmRFP expression driven in the ICM by (A) Oct4DE and in the TE by (B) fragment #1 
of Cdx2. Nuclei were stained with DAPI. Maximal projection is shown on the right. Scale 
bars, 10µm. (C) Representative transient transgenic embryos from fragments #1, #3 and 
#6 showing TE-specific lacZ reporter activity. 
2. Characterization of the Cdx2 TEE mouse lines. 
Having identified a Cdx2 TE-specific enhancer sequence, we generated stable mouse 
lines to screen for stage-specific TEE-driven activity in detail, avoiding the mosaicism 
inherent to transient transgenesis approaches. Mosaicism occurs because the 
microinjected DNA often integrates not in the zygote but after the embryo has already 
started to divide. Some cells will consequently have integrated the transgene whereas 
others will not, giving rise to genetically different cell populations. For this reason, 
mosaic embryos show heterogeneous reporter expression and do not reflect the 
possible regulatory capacity of the interrogated enhancer in every cell. In stable mouse 
lines, the transgene is stably integrated in the genome, and thus reporter expression 
will mimic endogenous regulatory capacity response in all cells. 
We generated several transgenic mouse lines using fragment #3 linked either to lacZ or 
to a H2BmRFP reporter gene and studied its enhancer capacity. Four stable transgenic 
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lines were analysed, three lacZ lines (lacZ-TEE) and one H2BmRFP mouse line (mRFP-
TEE). All the lines reproduced the TE-restricted expression pattern of the reporter gene 
at the blastocyst stage. We selected the H2BmRFP line and one of the lacZ lines for 
further analysis. 
Analysis of the mRFP-TEE line showed that the reporter is only occasionally active in a 
few cells at the eight-cell stage (Figure 11A), and upon compaction starts to be present 
in the outer cells of the morula (Figure 11B), attaining strong activity at the 16 cell stage 
(Figure 11C). At the blastocyst stage, TEE-driven reporter activity is localized throughout 
the TE and excluded from the ICM (Figure 11D). The Cdx2 lacZ-TEE reporter lines 
revealed an identical behaviour (Figure 11E). We used the nuclear localization of the 
H2BmRFP reporter protein to track blastomeres up to the 3.5 dpc blastocyst. Embryos 
with fewer than eight cells rarely showed any sign of reporter activity; upon 
compaction, at the 8-cell stage, around 40% of the blastomeres were TEE+, indicative 
of the first onset of TEE activation, and at the 16-cell stage, 88% of blastomeres were 
TEE+. These results point to an early activation of the TEE through signals concomitant 
with compaction. The number of blastomeres expressing mRFP increased during 
successive divisions (Figure 12D), with TEE+ cells accounting for ~60% of total 
blastomeres. At the blastocyst stage, reporter activity in the H2BmRFP and lacZ-TEE 
lines was found throughout the TE, although occasionally we detected positive cells in 
the ICM and cells with lower levels of expression in the TE (Figure 12C). 
Immunohistochemical analysis of the association between reporter activity and 
endogenous CDX2 showed concordant expression in >75% of blastomeres 
(CDX2+/TEE+, CDX-/TEE-; Figure 12A-C, E), confirming that TEE activity closely matches 
the first onset of CDX2 expression at preimplantation stages (Dietrich and Hiiragi, 2007; 
Strumpf et al., 2005). 
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Figure 11. mRFP- and lacZ-TEE lines drive restricted expression in the 
trophectoderm. 
(A-D) H2BmRFP reporter expression driven by the TEE at (A) the non-compacted 8-cell stage, (B) 
compacted 8-cell morula stage, (C) 16-cell stage, and (D) blastocyst stage. H2BmRFP was 
detected by immunohistochemistry and nuclei were stained with DAPI. (E) Temporal dynamics of 
a stable Cdx2 lacZ-TEE line at the 8-cell, morula, and blastocyst stages. Two different focal planes 
of the blastocyst are shown to evidence TE staining. Scale bars, 10 μm. 
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Figure 12. Cdx2 TEE reproduces the early onset of CDX2 expression. 
(A-C) Immunohistochemistry of TEE and CDX2 at the (A) eight-cell, (B) morula and the (C) 
blastocyst stage. Some TEE and below-normal CDX2 expression is still found in the ICM of the 
blastocyst (grey arrowhead). Arrowheads indicate CDX2+TEE+ (red) and CDX2+ TEE- (orange), as 
quantified in (E). (D) Quantification of the number of TEE-positive cells per embryo, staged by total 
cell number. Each dot represents an individual embryo, and bars and whiskers indicate means and 
standard deviations. (E) Correlation of TEE activity with endogenous CDX2 protein expression at the 
8-cell and 16-cell stages. 
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Next, we analysed the expression pattern of the TEE mouse lines at early post-
implantation stages. After implantation of the blastocyst into the uterus, the TE gives 
rise to all trophoblast derivatives of the conceptus: parietal trophoblast giant cells that 
line the implantation site, extraembryonic ectoderm (ExE), the ectoplacental cone, and 
later the various trophoblast cell types of the mature chorioallantoic placenta (Roper 
and Hemberger, 2009). Cdx2 is expressed in trophoblast derivatives (Beck et al., 1995) 
(Figure 13) and is a key transcription factor for the trophoblast lineage. Cdx2 -/- 
embryos die before implantation because the TE fails to maintain trophoblast identity 
and epithelial integrity, resulting in the collapse of the blastocyst (Strumpf et al., 2005). 
We expected to detect TEE mediated expression in the TE derivatives where Cdx2 is 
normally expressed such as the ExE of the early embryo. We dissected embryos at 6.5 
dpc and 7.5 dpc from both reporter lines and surprisingly did not detect any sign of 
reporter activity (Figure 13). This does not coincide with the Cdx2 endogenous 
expression pattern, since Cdx2 at these stages remains expressed in the TE-derived 
extraembryonic ectoderm. The lack of TEE reporter activity suggests that Cdx2 
expression at this stage requires other regulatory elements. 
 
Figure 13. Cdx2 TEE drives restricted expression in the trophectoderm 
but is inactive in the post-implantation embryo. 
(A) Cdx2 expression at blastocyst and post-implantation stages (red). (B) lacZ-TEE line 
reporter expression at 7.5 dpc. (C) CDX2 (green) and TEE (red) expression in the 6.5dpc 
post implantation embryo in the mRFP-TEE line. CDX2 and TEE are detected by 
immunohistochemistry with anti-CDX2 and anti-mRFP antibodies. CDX2 depicts 
extraembryonic ectoderm (ExE) expression, while TEE activity is absent at this stage. 
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3. TEE behaviour in trophoblast stem cells as a model of TEE function 
upon implantation. 
Three different stem cell subpopulations can be derived from blastocysts (Yamanaka et 
al., 2006). These populations have the ability to self-renew indefinitely in vitro and to 
differentiate into the various lineages of the tissue from which they originate. 
Moreover, they are a valuable tool for the study of aspects of stem cell biology, such as 
self-renewal and differentiation. The derivation of trophoblast stem (TS) cells from the 
TE mirrors the formation of the trophoblast from the TE after implantation. Cdx2 is the 
core component in TS cell maintenance as shown by the fact that TS cells cannot be 
derived from Cdx2 mutant blastocysts, showing that CDX2 is indispensable for TS cell 
self-renewal (Strumpf et al., 2005), and overexpression of Cdx2 in ES forces its 
conversion to TS cells (Niwa et al., 2005). The equivalence of TE and TS cells is 
confirmed by the contribution of TS cells, when injected back into a blastocyst, to the 
TE and its derivatives (Tanaka et al., 1998). 
We exploited the equivalence of TE and TS cells to study Cdx2 regulation in vitro. To 
investigate the differential activity of the TEE between the TE and the ExE, we 
transfected wild-type TS cells with putative Cdx2 cis-regulatory sequences, analysed 
chromatin status in the Cdx2 locus and derived TS cells from the lacZ and mRFP mouse 
lines. 
 TS cell transfections of regulatory elements. 3.1
To understand the possible mechanisms driving TEE activity, we first examined if the 
TEE drives reporter expression in wild-type TS cells. For this, we generated three RFP 
reporter constructs from fragments in the Cdx2 locus (Figure 14A): fragment I is a DNA 
sequence downstream of Cdx2 that has been characterized as a cryptic “shadow” 
enhancer in adult mouse liver (Watts et al., 2011); fragment II is an enhancer in the first 
intron of Cdx2, previously identified in the lab, that possesses enhancer activity in both 
ICM and TE; and fragment III is the TEE. Upon transfection into TS cells, fragment III 
showed no significant activity above that of empty vector (mock), contrasting with its 
competency to drive reporter expression in blastocyst. Fragment I, despite its “shadow” 
enhancer capacity, did not yield detectable RFP reporter expression, suggesting that it 
is a tissue specific enhancer and that the regulatory landscape of mouse liver and TS 
cells may be completely different. Interestingly, fragment II was able to drive RFP 
reporter expression in TS cells. This activity is in line with transient transgenic 
experiments in which this fragment directed reporter expression in both ICM and TE 
lineages of the blastocyst. These results thus show that the TEE is unable to induce the 
expression of a reporter gene in TS cells (Figure 14B). 
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 Analysis of the Cdx2 epigenetic landscape. 3.2
Analysis of epigenetic regulation of chromatin structure has emerged as a powerful way 
to identify cis-regulatory elements. Certain enhancer-associated chromatin features can 
be effectively used to annotate them. Chromatin signature at transcriptionally active 
promoters is remarkably similar across all cell types, with trimethylation of histone H3 
at lysine 4 (H3K4me3) being the most common modification (Heintzman et al., 2007). In 
contrast, active enhancers differ between cells and are marked by histone 
monomethylation (H3K4me1), histone acetylation (H3K27ac), binding of coactivator 
proteins (p300) or DNaseI hypersensitivity (DHS). Interestingly, H3K27ac distinguishes 
active enhancers from ‘poised’ H3K27ac-negative enhancers (Heintzman et al., 2007; 
Rada-Iglesias et al., 2011). 
We profiled histone modifications in the Cdx2 genomic region to identify the chromatin 
signature of the TEE in wild-type TS cells and to search for presence of other putative 
regulatory regions. Chromatin immunoprecipitation of histone marks followed by qPCR 
of selected regions in the Cdx2 locus was used to interrogate histone modifications 
across the regulatory sequences analysed by transgenesis and transfection assays. We 
selected primers covering the TEE (amplicons 8-12), an upstream intergenic region 
(amplicons 6-7), the Cdx2 promoter (promoter), the first intron (amplicons 3-5), and the 
region covering the 3’ enhancer (amplicon 2) (Figure 14A). 
For H3K4me3 ChIP, we included the housekeeping gene Actin as a positive control, 
used as an active promoter in TS cells. There are no reports showing enrichment for the 
H3K4me1 mark in TS-specific enhancers that we could use as positive control. As a 
negative control, we chose the Nanog promoter, which is not expressed in TS cells. 
ChIP for H3K4me3 and H3K4me1 showed that, as expected, the Cdx2 promoter region 
was enriched for H3K4me3 and depleted for H3K4me1. In agreement with our embryo 
transgenic and TS transfection assays for fragment II, we detected significant 
enrichment for H3K4me3 and H3K4me1 in the amplicon 4. In contrast, H3K4me1 was 
depleted over the TEE (amplicons 8-12), consistent with it not being active in TS cells. 
PCR products covering fragment I (2) were not enriched for H3K4me1 or H3K4me3 
(Figure 14C). These results indicate that the TEE does not possess active histone marks. 
In contrast, the first intron of Cdx2 shows enrichment for H3K4me1 and me3, in 
agreement with the results obtained by transient transgenesis with the same region. 
Although TS cells are derived from the blastocyst TE, these results suggest that Cdx2 
may be differentially regulated in the TE versus trophoblast-derived cells. 
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Figure 14. Cdx2 regulatory landscape analysis in TS cells. 
(A) Cdx2 locus, showing the position of the TEE, the promoter and exons of Cdx2. 
Arabic numerals show relative positions of amplicons used for ChIP experiments (2-12); 
Roman numerals show the relative size and position of Cdx2 fragments used for 
transfection assays (I, II and III). (B) TS transfection of different Cdx2 regulatory 
fragments. Fragments were tested for regulatory capacity and compared to the 
expression to the empty vector (mock). (C) Relative enrichment over IgG of H3K4me1 
(red) and H3K4me3 (blue) in a panel of selected Cdx2 regions and controls in the 
chromatin of TS cells. Data are means ± s.e.m. n=3. ***p<0.001 by Bonferroni post- 
test. 
 TS derivation from mRFP- and lacZ-TEE mouse lines. 3.3
Results from experiments with TS cells are reminiscent of the TEE behaviour in the post-
implantation embryo, where the mRFP- and lacZ-TEE mouse lines showed no sign of 
reporter activity in the ExE of 6.5 dpc embryos, in striking contrast to the TE-restricted 
expression of the TEE in blastocysts. However, TS cells are considered to be equivalent 
to the TE, because when TS cells are injected back into a blastocyst, they contribute to 
the TE and its derivatives. 
We decided to derive TS cells from the mRFP- and lacZ- TEE mouse lines (TSR and TSL 
respectively) to analyse reporter expression driven by the TEE when the transgene is 
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stably integrated in the genome. In this scenario, we expected the TEE to be inactive in 
TS cells, as already shown in TS transfections of fragment III. These cells would be a 
valuable in vitro tool to better characterize the differences between the in vivo 
regulation of Cdx2 expression in the trophectoderm and in the post-implantation 
trophoblast. 
From the 19 clones we derived (twelve TSL and seven TSR independent clones), we 
verified that four TSL and two TSR cell clones expressed appropriate levels of Cdx2 and 
of the other trophectoderm pluripotency markers, as shown by RNA expression analysis 
and immunohistochemistry (see section 13 of Materials and Methods). Next, we scored 
for reporter expression driven by the TEE. TSL cells from the lacZ-TEE mouse line did not 
express β-galactosidase driven by the enhancer (data not shown), and neither did the 
TSR cells derived from the mRFP-TEE line (Figure 15), consistent with TS transfections 
and chromatin status results. Hence, TS cells do not reproduce the TEE activity in the 
blastocyst. These results also indicate that additional inputs on the TEE may be absent 
or not sufficient to activate reporter expression in TS cells. They also suggest that 
different transcription factors may be responsible for Cdx2 regulation in the TE versus 
TS cells and post-implantation stages. 
 
Figure 15. TSR cells do not drive reporter activity. 
TSR cells do not show mRFP driven expression. Cells were stained for mRFP (red), CDX2 
(green) and DAPI (blue). 
The definitive demonstration that TS cells retain the same features as TE cells, other 
than their in vitro gene expression profile and their differentiation potential, is their 
ability to contribute to the TE when injected back into the preimplantation embryo. We 
therefore tested if TSR cells could indeed contribute to the TE and, if so, if they re-
expressed mRFP directed by the TEE when located in the embryo. 
To study if TS cells where able to activate the TEE and contribute to the TE, TSR cells 
were injected in the morula stage and their contribution to the TE of the blastocyst was 
assessed 24 hours later. After injection, injected cells mix with cells of the host, resulting 
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in the development of a mosaic embryo. To test if the TSR cells were able to contribute 
to the TE, we stained injected embryos for mRFP and CDX2 at the blastocyst stage. TSR 
cells were able to contribute to the TE, expressed CDX2, and, more importantly, were 
able to re-express the reporter, indicating that the enhancer is still functional (Figure 
16A). 
To better follow the behaviour of TSR cells in blastocysts and to make sure that 
H2BmRFP re-activation was occurring, we infected TSR cells with a lentiviral GFP 
construct, allowing tracking them after injection into the morula. To obtain a near-pure 
population of GFP-expressing cells we re-sorted TSR cells immediately before injection 
into morulae (Figure 16 B, C). 
Analysis of endogenous GFP and H2BmRFP reporter expression showed that TSR cells 
re-expressed the nuclear red fluorescent reporter. However, this was seen in only a 
proportion of TSR injected cells: some GFP+ TSR cells were able to contribute to the 
blastocyst without activating H2BmRFP reporter expression (Figure 16D). These cells 
appeared not to be allocated to the TE, and this might be the reason why they could 
not turn on the enhancer. It will be important to check which TE/ICM markers these TSR 
cells express in the blastocyst. 
 
Figure 16. TSR cells drive mRFP reporter expression in blastocysts. 
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(A) TSR cells re-express the mRFP-driven reporter. Embryos were stained for mRFP (red), 
CDX2 (green) and DAPI (blue). (B) GFP-infected TSR cells. Left panel shows a brightfield 
image of the cells. Right panel shows GFP expressing TS cells. (C) GFP+ TSR cell injection 
into a morula. (D) TSR cells re-express mRFP driven reporter. Endogenous expression of 
GFP (green) and H2BmRFP (red). White arrowheads point to GFP+,mRFP+ TSR cells, grey 
arrowheads show GFP+,mRFP- TSR cells. 
We conclude that the TEE is inactive in cultured TS cells and that necessary inputs are 
lacking in the culture system, because when the cells are re-inserted into the embryo, 
the TEE is still capable of driving reporter expression. Intriguingly, only a proportion of 
TSR cells infected with GFP were able to re-activate the transgene when injected back in 
morula, indicating a need for further characterization of the process. The fact that we 
also find a lack of reporter expression in cultured TSR cells suggests that two different 
regulatory mechanisms may be operating on Cdx2. Hence, TS cells in culture may 
reflect the TEE regulatory activity shown in the post implantation embryo, pointing to a 
stage dependent Cdx2 regulatory network in preimplantation versus the post-
implantation embryos. 
4. Searching for known upstream regulators of Cdx2 that act through 
the TEE. 
To better understand Cdx2 regulation during the first lineage choice, we decided to 
look for transcription factors that act upstream of the TEE to direct Cdx2 expression. 
Upon compaction, Cdx2 expression is upregulated and maintained specifically in the 
outermost population of the morula. Stabilization of Cdx2 in the prospective 
trophectoderm is triggered through a combination of inside versus outside positioning 
of blastomeres together with polarization and cell to cell contact cues. To date, the only 
transcription factor proposed to regulate Cdx2 concomitant with compaction is TEAD4, 
acting downstream of Hippo (Nishioka et al., 2009). In the context of the first lineage 
decision, Oct4 is involved in the maintenance of ICM versus TE fate through Cdx2 
repression around the time of implantation (Ralston et al., 2010). Both TE and ICM 
transcription factors show a complementary expression pattern, and it has been shown 
that both gene regulatory networks crosstalk. In ES cells, pluripotency expression 
patterns are reinforced by the reciprocal repression of Cdx2 by Oct4, Nanog and Sox2 
in ES cells (Boyer et al., 2005; Loh et al., 2006), also, it has be shown that CDX2 binds to 
and transactivates its own promoter and positively regulates its expression (Chew et al., 
2005). Moreover, CDX2 and OCT4 have been proposed to form a reciprocal inhibitor 
complex that may resemble what happens in the early embryo (Niwa et al., 2005). 
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  Analysis of the TEE response to CDX2 and OCT4.  4.1
To test if CDX2 regulates its own expression through the TEE in the early onset of CDX2 
restriction to outer cells, we examined homozygous Cdx2 -/- mice. In Cdx2 mutants 
blastocoel formation initiates, ICM lineage is specified, however epithelial integrity is 
not maintained and embryos fail to implant (Strumpf et al., 2005). In addition, mouse 
embryos are able to initiate TE specification and to polarize when Cdx2 is deleted 
maternal-zygotically. Thus, Cdx2 is not responsible for the first events that lead to TE 
formation (Blij et al., 2012). 
Analysis of Cdx2 -/- blastocysts revealed that TEE reporter activity was still restricted to 
the TE (Figure 17B). Counting of TEE+ blastomeres to rule out that the lack of Cdx2 
results in a reduced number of TEE+ cells revealed that the number of positive cells was 
the same as in wild-type littermates (Figure 17C), thus the TEE does not change its 
ability to drive reporter activity in the absence of Cdx2 and is upstream of Cdx2. 
 
Figure 17. The TEE is not an autoregulatory element. 
(A-B) Activity of the TEE, detected by immunohistochemistry with anti-mRFP (red) 
antibody, and immunodetection of CDX2 (green) in (A) wild-type (wt) and (B) Cdx2 -/- 
blastocysts. Nuclei were stained with DAPI. (C) Percentage of TEE-positive cells per wt 
and Cdx2 -/-.embryo. 
To test if OCT4-mediated repression of Cdx2 in the ICM occurs via the TEE, we took 
advantage of a genetically modified ES cell line (ZHBTc4) in which Oct4 is repressed by 
tetracycline. Upon tetracycline (Tc) addition, ES cells switch off the gene regulatory 
pluripotency program, convert to TS cells, and upregulate Cdx2. It has been suggested 
that this transdifferentiation switch could mimic the first lineage choice and the early 
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distinction between TE and ICM (Niwa et al., 2000). We took advantage of this system 
to address if derepression of TE genes through inactivation of Oct4 could lead to TEE-
driven mRFP activity. 
To set up the correct conditions, we tested different Tc doses (data not shown) and also 
tested Oct4 repression with Tc in ES or TS culture media. By immunohistochemistry, we 
were able to detect a downregulation of OCT4 upon drug administration (Figure 18A, 
C) and an upregulation of CDX2 48h post induction in EMFI-TS cultured cells (Figure 
18B, D). Expression profiling of Oct4, Nanog and Cdx2 by qPCR 48h after Tc 
administration detected a strong reduction of Oct4 and Nanog, concomitant with 
upregulation of Cdx2. The upregulation of Cdx2 was even stronger when Tc was added 
and cells were cultured in EMFI-TS medium, probably because this medium favours TS 
cell self-renewal and maintenance (Figure 18E). 
Next, we transfected ZHBTc4 ES cells with either empty vector, Oct4DE as positive 
control, or fragments from the Cdx2 regulatory locus previously used in the TS 
transfection assay (Figure 14, fragments I, II and III). Transfection of the selected 
regulatory sequences into ES cells after 48h in culture showed that Oct4DE directed 
robust expression of RFP, and that fragment II was moderately active in ES medium, in 
line with the results obtained in the lab by transient transgenesis of embryos in which 
this fragment is active in the ICM. When Oct4 was repressed by Tc and EMFI-TS 
medium added, activities of Oct4DE and fragment II were strongly reduced; in contrast, 
no RFP activity could be detected in neither the fragment III (TEE) nor fragment I (Figure 
18F). 
We therefore conclude that the TEE does not respond to the changes of gene 
expression patterns observed when cells switch from ES to a TS-like state upon Oct4 
repression, and hence the TEE is not the regulatory element responsible for the mutual 
maintenance and cross-repression through Cdx2 and Oct4. 
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Figure 18. The TEE does not respond to OCT4. 
OCT4 and CDX2 expression in ZHBTc4 cell line in ES medium or upon tetracycline 
induction in EMFI-TS medium. (A-C) OCT4 (green) staining (B-D) CDX2 staining (green) 
in ZHBtc4 cells; (Tc, 48h). Nuclei were stained with DAPI and F-actin with Rhodamine-
phalloidin (red) to detect cell membrane. (E) Relative expression of Cdx2, Oct4 and 
Nanog in the ZHBTc4 cell line in different culture conditions with and without Tc. (F) 
Percentage of ZHBTc4 cells that show reporter expression in transient transfections 
upon Tc addition. Data are means ± s.e.m. n=3. ***p<0.001, by Student’s t-test versus 
mock. 
 Analysis of the mRFP-TEE line response to the Hippo pathway. 4.2
Having ruled out an action of Cdx2 and Oct4 on the enhancer, we next analysed the 
regulation of the TEE by the Hippo pathway. The Hippo pathway is responsible for Cdx2 
regulation upon polarization in preimplantation stages; however, whether Tead4 
regulates Cdx2 directly is still not known as the Cdx2 trophoblast enhancer has not 
been identified (Nishioka et al., 2009). 
To check to what extent the TEE is a YAP/TEAD response element, we bred the mRFP 
reporter line to the Tead4 -/- background (Nishioka et al., 2008). Once the Hippo 
pathway is turned off, YAP shuttles to the nucleus where it binds to TEAD4. TEAD4 is 
the transcriptional effector of the pathway and its absence impedes the expression of 
target genes such as Cdx2. Analysis of the TEE in Tead4 mutants revealed that it was 
fully active in homozygous Tead4 -/- 3.5 dpc embryos, and even conserved preferential 
activity in outer blastomeres (Figure 19B). 
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Consistent with previous reports (Kaneko and DePamphilis, 2013; Nishioka et al., 2008), 
we also found that some Tead4 -/- embryos retained CDX2 expression (Figure 19C). 
Moreover, Cdx2 stochastic expression has been identified in eight-cell embryos where 
TEAD4 and YAP expression is ubiquitous (Dietrich and Hiiragi, 2007; Hirate et al., 2012), 
suggesting that additional inputs are necessary for the early expression of Cdx2. 
Furthermore, we did not detect significant differences in total cell number or RFP+ 
blastomeres per embryo between wild-type, heterozygous and homozygous embryos 
(Figure 19D), precluding an effect of the loss of Tead4 on the total number of cells in 
which the TEE is active. 
To investigate this further, we took advantage of the 5TVER7 ES cell line, which stably 
expresses a tamoxifen-inducible active form of the TEAD4 protein (Tead4VP16ER). This 
active form of the protein contains the Tead4 DNA binding domain fused to the 
transcriptional activator of the herpes virus VP16 and the estrogen receptor domain 
(ER). Upon tamoxifen induction, the fusion protein translocates to the nucleus and 
activates its target genes. When introduced in ES cells, they activate Cdx2 expression 
and acquire a TS cell phenotype (Nishioka et al., 2009). We transfected 5TVER7 cells 
with Fragments II, III (TEE) or with the Oct4DE as a control, and treated them with 
tamoxifen in EMFI-TS media. After 48 hours in these conditions, qPCR analysis showed 
robust activation of Cdx2 and downregulation of Oct4, accompanied by a marked 
decrease in Oct4DE activity (Figure 19E and F). Despite the forced expression of the 
active TEAD4 form, we did not observe a strong effect on fragment III (TEE) activity 
compared with culture in ES cell culture medium without tamoxifen, although 
treatment did increase activity slightly but significantly compared with control empty 
vector (Figure 19F). Interestingly, fragment II showed a relative sustained activity in 
both conditions suggesting a Hippo-independent regulatory mechanism. These 
experiments provide additional evidence that TEAD4 alone is not sufficient to fully 
activate the TEE. 
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Figure 19. The Hippo pathway is not sufficient to regulate the TEE. 
(A-B) TEE activity and TEAD4 immunodetection in (A) wild-type (wt) and (B) Tead4 -/-
embryos. (C) CDX2 expression in two Tead4 -/- embryos from the same litter. Nuclei were 
stained with DAPI. Maximal projections of merged images are shown in the right panels. 
Scale bars, 10 μm. (D) Percentage of TEE-positive cells per embryo in wt, Tead4 +/- and 
Tead4 -/- blastocysts. (E) Relative expression of Cdx2, Oct4 and Nanog in the 5TVER7 and 
(F) percentage of 5TVER7 cells that activate the TEE in response to tamoxifen (Tx). Data 
are means ± s.e.m. n=3. **p<0.01, *p<0.05 by Student’s t-test compared to mock. 
Searching for unknown upstream regulators
 
57 
5. Searching for unknown upstream regulators of Cdx2 that act through 
the TEE. 
The above results suggested that there must be other pathways responsible for the 
early expression of Cdx2. To identify other transcriptional inputs acting on the TEE, we 
looked for transcription factors that may relate the TEE to its early activation. This 
analysis was carried out in silico, using the FIMO (Find Individual Motif Occurences) 
software program. We searched the whole upstream region of Cdx2 up to the next 
gene, a distance of 9.6kb (Figure 9), for putative binding sites specifically enriched on 
the TEE. In the search we included RBPJ, the transcriptional effector of the Notch 
pathway (Kopan and Ilagan, 2009). Interestingly, over the 9.6kb span, six out of seven 
RBPJ predicted binding sites were included in the TEE sequence (Figure 20). The 
remaining predicted site was at the Cdx2 promoter. 
 Characterization of the Notch pathway in early preimplantation. 5.1
Compaction brings about a distinction between two cell populations: an external 
population of polarized cells and an apolar inner cell population. Position and 
polarization are key features of early development and the role of Notch-mediated cell-
to-cell signalling and cell fate decisions during development is well established (Koch et 
al., 2013), although no role in early preimplantation has been assigned. There is scant 
evidence available for the expression of Notch pathway components at this stage 
 
Figure 20. Identification of putative RBPJ binding sites. 
(A) RBPJ motif logo generated to identify the putative binding sites according to the 
position-specific scoring matrix from the literature (Tun et al., 1994) (B) High scoring motif 
occurrences in the 9.6kb region for RBPJ sites identified by FIMO. TEE location, strand, p-
value, position and sequence are indicated. (C) Location in the Cdx2 locus of the predicted 
RBPJ binding sites (pink). Identified fragments that contain TEE activity as in Figure 9 are 
shown. The majority of RBPJ sites are included in the TEE. 
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(Cormier et al., 2004; Wang et al., 2004), and no studies have addressed their 
differential localization. To investigate the role of Notch pathway in preimplantation 
development, we studied its spatial localization in the early mouse embryo. 
To examine the activation status of the Notch pathway during preimplantation stages 
we used a mouse line containing a CBF:H2B-Venus reporter, which contains multiple 
RBPJ binding sites driving the expression of a nuclear-targeted Venus fluorescent 
protein and that faithfully reports the activation state of the pathway (Nowotschin et al., 
2013). The reporter was active in a few cells at the 8-cell stage, showed stochastic 
expression in morula stage and its activity became progressively restricted to outer cells 
by the 3.5-dpc blastocyst stage (Figure 21A-C). In addition, we examined reporter 
activity together with endogenous CDX2 expression in early blastocysts of this line, 
finding that CBF:H2B-Venus reporter colocalized with CDX2 in the nascent TE (Figure 
21D). To confirm reporter specificity, we treated embryos from CBF:H2B-Venus reporter 
line with the gamma-secretase inhibitor RO4929097 (RO). RO is a well characterized 
and widely used tool that interferes with Notch signalling by blocking the processing of 
the receptor (Munch et al., 2013). Treatment of embryos from this line with the inhibitor 
resulted in a strong downregulation of the reporter (Figure 21E). 
Finally, we studied the endogenous distribution of the NOTCH1 (N1ICD) intracellular 
domain. N1ICD is the active processed form of Notch receptor. Upon interaction with 
the ligand, NOTCH receptor is cleaved and N1ICD translocates into the nucleus where it 
binds RBPJ and activates its target genes (Figure 6). Immunofluorescence detection of 
N1ICD in embryos showed that it is localized to the nucleus only in the outer cells of 
the blastocyst (Figure 21F). Together, these data show that the Notch signalling 
pathway is active specifically in the developing TE. 
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Figure 21. The Notch signalling pathway is active in the trophectoderm. 
(A-C) CBF:H2B-Venus reporter expression at (A) the non-compacted 8-cell stage, (B) 
morula stage, and (C) blastocyst stage. (D) Detection of CBF:H2B-Venus reporter (green) 
and CDX2 (red) at the blastocyst stage. Grey arrowhead points to a low level CDX2-
expressing cell. (E) Treatment of embryos from the CBF:H2B-Venus line with the g-
secretase  inhibitor RO4929097 (RO) downregulates reporter activity as compared to 
controls incubated in DMSO. (F) Immunodetection of NOTCH1 intracellular domain 
(N1ICD, red). Nuclei were stained with DAPI. Scale bars, 10 μm 
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 Notch activity in TS cells. 5.2
The TE-specific expression of active Notch shown above suggested that Notch 
components might be differently distributed in TS cells versus ES cells. Surprisingly, 
CBF:H2B-Venus ES cells still express the reporter in a subpopulation of cells 
(Nowotschin et al., 2013), although in this mouse strain no reporter expression is 
detected in the ICM, from where the ES cells are derived (Figure 21). Moreover, all 
Notch pathway components are expressed in ES and in TS cells (Cormier et al., 2004), 
and Jagged1 receptor has been immunodetected in ES cells (Lowell et al., 2006). To try 
to resolve the discrepancy between the expression pattern we observe in the ICM of 
the blastocyst and findings in cultured cells, we studied N1ICD expression in blastocyst-
derived ES and TS cells. 
As a positive control, we therefore used human umbilical vein endothelial cells 
(HUVEC), a widely used model for the study of endothelial-cell function and pathology 
that strongly express Notch pathway components (Figure 22A) (Shawber and Kitajewski, 
2004; Uyttendaele et al., 2001). In TS cells, we could detect N1ICD in a limited number 
of nuclei (Figure 22B). To validate N1ICD expression in other TS cell lines, we stained for 
N1ICD in TSR cells, detecting the same expression pattern (Figure 22C). Strikingly, 
staining of the active form of Notch1 was heterogeneous in both TS cell lines, while in 
the blastocyst, an even distribution of N1ICD was found throughout the TE. In contrast, 
and contrary to what has been shown with the CBF:H2B-Venus reporter, no specific 
signal was detected in ES cells (Figure 22D). This result suggests that ES cells might 
express other Notch receptors that are not present in the ICM, or that the expression 
levels of the fluorescent protein are stronger and thus more easily detectable than 
endogenous N1ICD. 
Together, this data indicate that analysis of N1ICD in blastocyst-derived stem cells does 
not mimic completely its expression pattern in blastocysts. Thus, to better understand 
the Notch pathway in preimplantation stages, ES and TS cells do not seem a consistent 
in vitro tool. 
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Figure 22. TS cells contain N1ICD heterogeneous levels. 
(A-D) Immunodetection of N1ICD (green) in (A) HUVEC, (B) TS cells, (C) TSR cells and (D) 
ES cells. N1ICD is present in all (A) HUVEC nuclei, but only a few nuclei (B) TS and (C) TSR 
cells. (D) ES cells show no sign of expression. Nuclei were stained with DAPI and the 
merge image is shown. 
 Functionality of the identified TEE RBPJ and TEAD binding sites. 5.3
To characterize the possible direct link between RBPJ (the Notch pathway) and Cdx2, 
we analysed the minimal 1.3 kb TEE sequence (fragment #6, Figure 9) for bona fide 
RBPJ sites, detecting four high-confidence sites for RBPJ. Given that we detected a 
slight but significant increase in TEE activity when Tead4VP16 was overexpressed (refers 
to section 4.2), we also searched for putative TEAD binding sites (Anbanandam et al., 
2006) and identified two. 
To investigate the function of the identified sites in the minimal TEE fragment (fragment 
#6), we generated transient transgenic embryos expressing the wild-type minimal TEE 
or versions mutated in the four RBPJ sites alone (TEERBPJmut), the two TEAD sites alone 
(TEETEADmut) or in the RBPJ and the TEAD sites (TEERBPJ/TEADmut) (Figure 23A). The 
mutated constructs contained substitutions of the minimal nucleotides that have been 
shown to abolish RBPJ binding (Tun et al., 1994). We then tested the capacity of each 
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construct to drive reporter expression by transient transgenesis. Transgenic embryos 
carrying the TEERBPJmut or the TEETEADmut version retained TE lineage-restricted activity 
as was the case for the TEE, while TEE activity was abolished when the RBPJ and TEAD 
sites were together mutated (Figure 23B). 
The lack of response of the individual RBPJ and TEAD sites suggests that the enhancer 
responds in a redundant fashion in the blastocyst and that the activity is only reduced 
when a combination of mutated binding sites is used. 
 
Figure 23. RBPJ together with TEAD binding sites are necessary for the 
activity of the Cdx2 TEE. 
(A) The different TEE fragment #6 versions with the identified putative binding sites for 
RBPJ (pink) and for TEAD (blue). (B) Activity of wild type TEE, TEERBPJmut, TEETEADmut and 
TEERBPJ/TEADmut constructs in transient transgenic embryos. In TEERBPJ/TEADmut embryos, no 
TE-specific activity was observed. Nuclei were stained with DAPI. Scale bars, 10 μm. 
As shown above, the TEE is able to respond with similar efficiency when the mutated 
sites for either RBPJ or TEAD are present. In this scenario, the input from the remaining 
pathway is sufficient to induce TEE driven reporter expression. To study the effect on 
the TEE of each pathway when the other input is missing, we microinjected mutated 
TEE constructs and treated the embryos with pharmacological blockers of the Notch 
and Hippo signalling pathways. The day after microinjection, surviving 2-cell stage 
embryos were divided in two pools and treated either with the solvent used to prepare 
the drug (vehicle) or with the pharmacological inhibitor and cultured for three days 
(Figure 24A). Embryos that reached the blastocyst stage where scored for RFP 
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expression and classified as TE specific, unspecific (TE+ICM), or weak in cases were 
embryos showed less than four RFP+ cells or generally low RFP intensity. 
Notch pathway disruption in embryos microinjected with TEETEADmut by treatment with 
the gamma-secretase inhibitor RO4929097 (RO) strongly reduced the number of 
transgenic embryos showing TE specific expression compared with microinjected 
controls incubated with DMSO (Figure 24B, D). This result confirms that attenuation of 
Notch signalling diminishes activity of a TEE that lacks functional TEAD sites. 
 
Figure 24. Notch and Hippo are responsible for full enhancer activity 
through the identified binding sites. 
(A) Experimental setup for inhibitor or vehicle treatment of embryos from the same batch of 
microinjected embryos. (B) TEETEADmut activity in transient transgenic embryos treated with 
DMSO, the TEAD/YAP inhibitor VP or the γ-secretase inhibitor RO. (C) TEERBPJmut activity in 
transient transgenic embryos treated with DMSO, RO or VP. (D) Percentage of transgenic 
expression (TE, TE + ICM, or weak) in embryos microinjected with the TEE, TEETEADmut or 
TEERBPJmut versions and treated with the indicated inhibitor. **p<0.01, ***p<0.001 by Chi 
squared test. 
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As for the Hippo pathway, we used verteporfin (VP), a small molecule that inhibits 
TEAD–YAP association (Liu-Chittenden et al., 2012). To confirm that VP disrupts Hippo 
signalling as expected, we treated embryos from the mRFP-TEE reporter line and 
examined reporter activity together with endogenous CDX2 expression (Figure 25). A 
high percentage of VP treated embryos phenocopied Tead4 -/- embryos (Figure 19), 
with strong reduction of CDX2 but retention of TEE activity (Figure 25). 
Verteporfin treatment on TEERBPJmut microinjected embryos significantly reduced TE 
specificity (Figure 24C, D), showing that interfering with the transcriptional activity of 
YAP and TEAD4 when the RBPJ sites are missing decreases enhancer activity. As 
expected, treatment of TEERBPJmut microinjected embryos with RO, or TEETEADmut 
microinjected embryos with VP had no significant effect on the TE specificity of reporter 
activity (Figure 24). 
Taken together, these results show that transcriptional inputs from both pathways are 
responsible for full enhancer activity through the specific binding sites identified, acting 
in a redundant fashion in vivo. 
6. Does the Notch signalling pathway together with Tead4 regulate 
Cdx2 trough the TEE? 
To further explore the regulation of the TEE by Notch, we tested its activity in the 
absence of Notch signalling by breeding the mRFP-TEE line in the Rbpj -/- background. 
Absence of the transcription factor Rbpj impedes the recruitment of the coactivator 
complex to activate Notch target genes, thus making the cell unresponsive to Notch 
signalling (Oka et al., 1995). 
Figure 25. Verteporfin 
treatment 
phenocopies Tead4 -/-. 
Effect of the TEAD–YAP 
inhibitor verteporfin (VP) on 
treated mRFP-TEE embryos 
from the 2-cell stage. 
Immunodetection of TEE 
activity (red) and CDX2 
(green). Nuclei were stained 
with DAPI. Maximal 
projections of merged images 
are shown in the right panels. 
Scale bars, 10 μm. 
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Consistent with the activity of TEE RBPJmut in the TE (Figure 23), Rbpj +/- and Rbpj -/- 
embryos showed normal TEE-driven expression, as was the case for Tead4 +/- and  
Tead4 -/- embryos (Figure 26A-C, Figure 19). These embryos also had normal numbers 
of cells and of TEE+ blastomeres, although Rbpj -/- embryos showed a notable but 
statistically non-significant tendency to have fewer TEE+ cells than wild-type embryos 
(Figure 27A). Altogether, these results demonstrate that inactivation of a single pathway 
is not sufficient to abolish the ability of the TEE to drive RFP expression and suggest 
that the TEE compensates the lack of one of the inputs to ensure its activity. 
In previous results, we observed a combinatorial effect of Hippo and Notch, with TEE 
activity lost only when both RBPJ and TEAD sites were mutated. Also, TE specificity was 
significantly reduced when single TEE mutated versions were pharmacological 
disrupted for the converse pathway (see 5.3). To further test for interaction between 
Notch and Hippo on the TEE, we generated embryos of the mRFP-TEE line containing 
different combinations of Tead4 and Rbpj mutant alleles. Double heterozygote 
embryos (Rbpj +/-;Tead4 +/-) contained significantly fewer than normal TEE+ cells (Figure 
26D, Figure 27A) and this effect was more marked in Rbpj -/-;Tead4 +/- embryos, where 
only a few mRFP cells were detected in the TE (Figure 26E, Figure 27A). This was not 
due to disruption of overall cell number or the inside-outside distribution of 
blastomeres in these embryos, as these parameters showed no significant difference 
compared with wild type, Tead4 +/-, Rbpj +/- or Rbpj -/- blastocysts (Figure 27B).The 
reduction in RFP+ blastomeres in double heterozygotes suggests that activation of the 
TEE requires minimum threshold amounts of TEAD4 and RBPJ, since the lack of one 
copy of each is enough to reduce the number of TEE+ cells. Unexpectedly, we did not 
recover any double homozygote knock-out embryos at 3.5 dpc and the frequency 
distribution did not follow Mendelian ratios, suggesting that the combined lack of 
these two factors causes the death of embryos at an earlier stage (Figure 27C). 
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Figure 26. TEE activity and Cdx2 expression require transcriptional inputs 
from Notch and Hippo. 
(A-E) TEE activity and CDX2 immunodetection in (A) Tead4 +/-, (B) Rbpj +/-, (C) Rbpj -/-, (D) 
Rbpj +/-;Tead4 +/-, and (E) Rbpj -/-;Tead4 +/- mutant embryos. Nuclei were stained with 
DAPI. Arrowheads in (C-E) indicate TEE-, CDX2+ outer blastomeres. Maximal projections 
of merged images are shown in the right panels. Scale bars, 10 μm. 
Analysis of the TEE enhancer regulation by the Notch pathway and Tead4 showed a 
reduction in TEE+ cells and no double homozygous knock-out could be detected, 
suggesting an unexpected early role of Notch in combination with Tead4 in 
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preimplantation development. However, quantification showed no difference in the 
total number of CDX2+ cells per embryo in the different genotypes (Figure 27B). Of 
note, Rbpj -/-, Rbpj +/-;Tead4 +/- and Rbpj -/-;Tead4 +/- mutants contained blastomeres in 
which we could detect outer blastomeres expressing CDX2 but not the TEE (arrowheads 
Figure 26C-E), indicating that Cdx2 regulation does not solely rely on the TEE regulatory 
sequence. 
 
Figure 27. Rbpj and Tead4 happloinsuficient embryos show reduced 
TEE+ cells and double knock-outs die before 3.5 dpc. 
(A) Percentage of TEE-positive cells per embryo in wild type blastocysts and in Tead4 +/-, 
Rbpj +/-, Rbpj -/-,Rbpj +/-;Tead4 +/-  and Rbpj -/-;Tead4 +/- allelic combinations. *p<0.05, 
***p<0.001 by Bonferroni post-test. (B) Average number of inside and outside cells 
positive or negative for CDX2 in wild-type, Tead4 +/-, Rbpj +/-, Rbpj -/-, Rbpj +/-;Tead4 +/- 
and Rbpj -/-;Tead4 +/- allelic combinations quantified in Figure 28.(C) Distribution (%) of 
embryos for the different allelic combinations. The distribution does not follow 
Mendelian ratios; **p<0.005 by chi-square test. 
Taking into account that the TEE is a faithful Cdx2 regulatory element and that the TEE 
responds to both Notch signalling and Tead4, we thought that cell number differences 
in the mRFP-TEE line when we compared the different genotypes could reflect subtle 
endogenous changes in Cdx2 levels. We therefore used our segmented data on single 
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embryos to quantify CDX2 mean intensity per blastomere. Quantification of CDX2 
protein per blastomere revealed significantly below-normal expression in Rbpj -/-,Rbpj 
+/-;Tead4 +/- and Rbpj -/-;Tead4 +/- embryos, but not in Rbpj or Tead4 single 
heterozygotes (Figure 28A). Notch signalling and RBPJ are thus necessary for proper 
expression of endogenous Cdx2 in the embryo, in cooperation with TEAD4. 
 
Figure 28. Cdx2 expression requires transcriptional inputs from Notch 
and Hippo. 
(A) Quantified CDX2 expression in outer cells of wt blastocysts and in Tead4 +/-, Rbpj +/-, 
Rbpj -/-, Rbpj +/-;Tead4 +/- and Rbpj -/-;Tead4 +/- allelic combinations. Boxes span the 25th 
to the 75th percentile, internal horizontal lines indicate median values, and whiskers show 
minima and maxima. ***p<0.001 by Bonferroni post-test. (B) Relative expression of Cdx2, 
Gata3, Eomes, Oct4 and Nanog in pools of 25 embryos treated from 2-cell until 
blastocyst stage with DMSO or RO. Data are means ± s.e.m. **p<0.01 by Student’s t-test. 
We confirmed the effect of Notch on Cdx2 expression by treating pools of embryos 
from the 2-cell to blastocyst stages with the γ-secretase inhibitor RO, which significantly 
decreased mRNA expression of Cdx2. We also examined changes in expression of other 
TE-expressed genes, finding that neither Gata3 nor Eomes changed significantly (Figure 
28A). This might reflect the earlier requirement of Cdx2 and the fact that Gata3 and 
Eomes only function later in TE development (Ralston et al., 2010; Strumpf et al., 2005). 
We did not detect any change in Oct4 or Nanog. This result confirms that Notch 
inhibition specifically downregulates Cdx2 expression and that no alteration in the 
pluripotency transcription factors can be detected. 
To verify the response of the TEE to the Notch pathway together with Tead4, we 
pharmacologically repressed TEE activity by treating embryos with RO together with VP 
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(for RO and VP information, see results page 61). Consistent with the genetic analysis, 
combined treatment of embryos from the mRFP-TEE transgenic line with both 
inhibitors strongly reduced TEE activity and endogenous CDX2 expression (Figure 29) 
confirming the genetic analysis results. 
 
Figure 29. TEE activity is reduced by VP + RO treatment. 
TEE activity (red) and CDX2 immunodetection (green) in embryos from the mRFP line 
treated with DMSO or RO+VP from 4-cell stage until blastocyst stage (left panel). Maximal 
projections of merged images are shown in the right panels. Nuclei were stained with 
DAPI. Scale bars, 10 μm. 
Our results hence show that the Notch and Hippo pathways act together in the 
preimplantation embryo, affecting TEE activity, CDX2 expression and embryo viability. 
7. Analysis of a Notch gain of function model. 
To further characterize the role of Notch in trophectoderm specification and to 
complement the analysis of Notch pathway loss-of-function, we used a gain-of-
function model to examine the effects of forcing Notch expression in atypical spatial 
and temporal patterns at the stage of the first lineage choice. For this, we 
overexpressed the active form of NOTCH1 in the preimplantation embryo by crossing a 
R26-stop-N1ICD-ires-nEGFP line (RosaNotch) (Murtaugh et al., 2003) with a line carrying a 
maternal Sox2-Cre allele (Hayashi et al., 2002) (Figure 30A). In the RosaNotch line, in the 
absence of Cre recombinase, transcription of the modified locus is blocked by the STOP 
sequence; in the presence of Cre, the Neo/STOP cassette will be deleted, yielding 
heritable, constitutive coexpression of Notch1 intracellular domain (N1ICD) and nuclear 
enhanced GFP (nEGFP). Targeting of the permissive Rosa26 locus using the Rosa26 
endogenous promoter and a STOP fragment flanked by loxP sites generates a 
ubiquitous yet moderate level of expression upon loxP recombination (Srinivas et al., 
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2001). The Sox2-Cre allele has been shown to be an efficient epiblast driver at 6.5 dpc 
and maternal Sox2-Cre recombination can induce full germline recombination (Hayashi 
et al., 2002). 
 Cdx2 expression analysis of RosaNotch overexpressing blastomeres. 7.1
To overexpress active Notch starting in the zygote, we crossed Sox2-Cre females with 
RosaNotch males so that the recombination would start upon fertilization. Most 
blastocysts obtained from this cross were viable (80%, n=58), as shown by the presence 
of a blastocoele and proper CDX2 expression in outer cells (Figure 31B). This indicates 
that embryos are able to develop until the blastocyst stage when Notch pathway is 
constitutively active. 
 
Figure 30. Rosa Notch gain of function model. 
(A) Breeding strategy for the ♂R26-stop-N1ICD-ires-EGFP X ♀Sox2-Cre cross (B) 
Expression of the GFP reporter from the Rosa Notch line (green) and CDX2 (red) when 
recombined by maternal Sox2-Cre detected by immunochemistry. White arrowheads 
mark non-recombined cells. Nuclei were stained with DAPI. Scale bars, 10 μm. 
As the Sox2-Cre is provided maternally, CRE is already expressed in the oocyte and 
recombination occurs right after the Rosa Notch allele is delivered. Although this strategy 
predicts uniform recombination in all cells of the blastocyst, we unexpectedly found 
mosaic expression of the reporter at 3.5-4.0 dpc (23 % GFP- blastomeres; arrowheads in 
Figure 31B, Figure 31B,C).The degree of mosaicism in the Rosa Notch embryos ranged 
from zero recombined cells to fully recombined blastocysts (Figure 31B). To check for 
mosaic recombination, we genotyped individual embryos for the presence or absence 
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of Neomycin (Neo). The Neo/STOP fragment flanked by loxP sites is recombined upon 
CRE expression and consequently a PCR product will only be detected when 
recombination has not occurred. We confirmed the presence of the non-recombined 
allele in blastocysts obtained from this cross by PCR (Figure 31A), indicating mosaicism. 
Moreover, to rule out the possibility that the mosaicism was due to undetectable GFP 
expression due to lower efficiency of GFP IRES-mediated translation compared with 
N1ICD translation, we used a R26-stop-YFP reporter (Rosa YFP) (Srinivas et al., 2001) that 
does not contain an IRES (internal ribosome entry site). In this case, we were also able 
to detect mosaic recombination when crossed to the maternal Sox2-Cre allele (Figure 
31C). 
 
Figure 31. Mosaicism of maternal Sox2-Cre activity in the blastocyst. 
(A) Detection of mosaic recombination in blastocysts by PCR of Neo. Arrowheads indicate 
the varying degree of detection of the non-recombined allele in different embryos, from 
low (grey) to high (black); embryo 2, and 5 are shown in (B). (B) Example of Rosa Notch 
blastocyst with a very high proportion of non-recombined cells (#2) and of a blastocyst 
with recombination occurring in all cells (#5). (C) Mosaicism of GFP reporter expression 
(green) from the Rosa YFP line when recombined by maternal Sox2-Cre. White arrowheads 
mark non-recombined cells. Nuclei in were stained with DAPI. Scale bars, 10 μm. 
The fact that embryos contained N1ICD-overexpressing, GFP-labelled blastomeres 
confronted to blastomeres expressing endogenous levels of the pathway prompted us 
to analyse whether GFP+ and GFP- populations differ in their levels of Cdx2 expression. 
This allowed us to directly interrogate if Notch overexpression increases Cdx2 
endogenous levels. We first plotted the mean CDX2 intensity for non-overexpressing 
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(N1OE-) and N1ICD-overexpressing (N1OE+) blastomeres. We included blastomeres in 
the ICM, which would be expected to show low levels of CDX2, and TE blastomeres in 
outer positions that would be expected to have higher levels of CDX2, independently of 
NOTCH1 overexpression. Quantification of CDX2 staining at the blastocyst stage 
showed that blastomeres overexpressing N1ICD have higher levels of CDX2 protein 
irrespective of their position (Figure 32A). We then analysed only outer cells (those that 
would normally express Cdx2) and the same pattern was found (Figure 32B), showing 
that in a population where CDX2 levels are already high, Notch overexpression induces 
even higher levels of expression. These results complement the earlier observation of 
reduced CDX2 in Rbpj mutant embryos (Figure 28), and confirm that the Notch 
pathway directly regulates Cdx2 expression. 
 
Figure 32. Notch overexpression regulates Cdx2 expression. 
(A) Quantified CDX2 expression in all N1ICD-overexpressing (N1OE+; green) and non-
overexpressing (N1OE-) blastomeres in embryos generated from the ♂R26-stop-N1ICD-
ires-EGFP X ♀Sox2-Cre cross. (B) Quantified CDX2 expression in outer N1OE+ and N1OE- 
blastomeres. Boxes span the 25th to the 75th percentile, internal horizontal lines indicate 
median values, and whiskers show minima and maxima. ***p<0.001 by Student’s t-test. 
 Rosa Notch overexpressing blastomeres allocate preferentially in the TE of 7.2
the blastocyst. 
In this set of experiments, we also noticed that the TE of Rosa Notch embryos contained 
more blastomeres than wild-type embryos and it appeared that GFP+ blastomeres 
were more often localized to the TE. We took advantage of the mosaicism to analyse 
the spatial distribution of blastomeres overexpressing N1ICD in more detail. We 
compared wild-type and Rosa Notch embryos that did not show any difference in total 
cell number (Figure 33A) and quantified wild-type, N1OE- and N1OE+ blastomeres 
allocated to the outside or inside as a percentage of all blastomeres. Whereas GFP- 
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(N1OE-) blastomeres from mosaic embryos showed an inside-outside distribution 
similar to that of blastomeres from wild-type blastocysts, GFP+ (N1OE+) blastomeres 
were significantly more abundant in outside positions (Figure 33B). These results 
suggest that N1ICD-overexpressing blastomeres not only express higher levels of CDX2 
but also have a higher probability of being allocated to the TE. 
We next wanted to understand the distribution of N1OE+ versus N1OE- blastomeres 
per embryo. In wild-type embryos, we found that around 65% of the blastomeres are 
located outside. In contrast, in Rosa Notch embryos, the percentage was significantly 
higher (75%), confirming that Rosa Notch embryos have more outer, TE cells. Comparison 
of the proportions of outer and inner GFP+ cells in the Rosa Notch embryos showed that, 
N1OE+ cells were overrepresented in the TE population compared with inner cells 
(81.3% vs 64%; Figure 33C). These results indicate that blastomeres in which the Notch 
pathway is active localize preferentially to the outer TE population, and that cells can be 
directed to this population by forced overexpression of the active form of NOTCH1. 
 
Figure 33. Notch instructs cells to adopt an outer position in the 
blastocyst. 
(A) Average cell number in wild-type (wt) and RosaNotch blastocysts. (B) Inside/outside 
distribution of all N1OE+ and N1OE- blastomeres compared with the distribution of wild 
type (wt) blastomeres. ***p<0.001 by Chi squared test. (C) Distribution per embryo of 
inner (grey) and outer cells (white) in wild-type (wt) and N1ICD-overexpressing embryos. 
For N1OE embryos, the contribution of GFP+ cells (green) to each population is also 
shown. 
RESULTS
 
74 
In this work, we have been able to identify for the first time a Cdx2 TE-specific enhancer 
and by generating transgenic mouse lines, we have been able to follow the dynamics of 
activation of the cis-regulatory sequence during the early stages of mammalian 
development and in TE-derived TS cells. Moreover, we have attempted to define how 
this element is regulated in order to better understand Cdx2 regulation. By analysing 
known and unknown inputs upstream of Cdx2, we have found that Notch is a 
previously unidentified upstream regulator of Cdx2. Analysis of Notch loss- and gain-
of-function models has revealed a novel role for the Notch signalling pathway during 
early preimplantation development. 
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“If it was so, it might be; and if it were so, it would be; but as it isn't, it ain't. 
That's logic." 
Through the Looking-Glass. LEWIS CARROLL 
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DISCUSSION    
1. Two-stage regulation model for Cdx2. 
The mammalian zygote possesses the intrinsic capacity to initiate the process 
leading to differentiation and formation of an adult organism without any 
environmental cue. This has been proven in experiments where a single blastomere 
was isolated from the embryo. In these surgical experiments, the remaining 
blastomeres in the embryo compensated the loss and continued to develop 
normally. Moreover, the isolated blastomere was able to give rise to a wide variety 
of cell types. The ability of embryonic cells to change their fates to compensate for 
the missing parts during embryogenesis has been termed regulative development. 
The commitment of a cell depends upon the conditions in which the cell finds itself 
and there is no pre-patterning. Crosstalk within cells in the embryo is thus crucial for 
proper embryo progression. 
Despite knowledge gained in the past few years, we still lack a precise 
understanding of the mechanisms that describe how pattern and lineages emerge 
in the early mouse embryo. We have a good understanding of the core set of 
transcription factors responsible for the establishment and maintenance of the first 
lineages (Cockburn and Rossant, 2010; Nishioka et al., 2009; Rossant and Tam, 
2009), but little is known about how the expression of these factors themselves is 
initiated and then limited to specific subpopulations of cells in the embryo. Lineage 
restriction of genes such as Cdx2, a key factor in the TE lineage, is thought to be 
triggered by a combination of stochastic early expression together with 
morphological cues provided by the process of compaction and polarization of 
outside cells. 
Stochastic expression in preimplantation development has been described as the 
capacity of single cells to express a random combination of key genes involved in 
the first lineage choice (Cdx2, Oct4, Sox2 and Nanog). Immunohistochemistry on 
fixed embryos throughout development showed heterogeneous expression of the 
pluripotency regulatory networks, revealing no direct correlation among them 
(Dietrich and Hiiragi, 2007). Although this approach provides an interesting insight 
into the mechanisms that underlie the expression pattern of the factors, it still relies 
on the availability and sensitivity of the antibodies used. Stochastic expression has 
also been confirmed by single blastomere transcriptome profiling at early 
preimplantation stages. RNA profiling revealed that the core factors that 
subsequently become cell-type restricted in the blastocyst are co-expressed at high 
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levels in most blastomeres of the 16-cell embryo, and it is not until the 32-cell stage 
that cells are assigned to a TE or ICM lineage (Guo et al., 2010). The heterogeneous 
expression of the lineage transcription factors confers plasticity to the regulative 
embryo. The fate choice is taken only when the factors are stably maintained in 
cells. 
An issue that remains unresolved is the in vivo dynamics of each transcription factor, 
in other words whether the apparent heterogeneity of the transcription factors at 
early stages arises from their random upregulation and downregulation within a 
blastomere. Although the study of OCT4 kinetics has revealed an important role in 
lineage patterning (Plachta et al., 2011), there is still a scarcity of tools with which to 
track transcription factor dynamics within embryos. 
The identification of non-coding regulatory sequences for the main transcription 
factors would permit a better understanding of the dynamic expression profile of 
this set of genes and may serve as an approach to decipher the heterogeneity of 
each transcription factor within a blastomere. Also, the characterization of the 
minimal enhancer sequence responsible for full regulatory activity allows 
interrogation of the sequence and identification of putative binding sites for factors 
that may link the heterogeneity we see in the expression pattern with morphological 
and topological cues in the embryo. There have been some reports identifying 
enhancers for the core pluripotency factors Oct4 Sox2 and Nanog (Catena et al., 
2004; Jiang et al., 2008; Levasseur et al., 2008; Tomioka et al., 2002; Yeom et al., 
1996; Yoshimizu et al., 1999). However, most of the work has been performed on ES 
cells and their capacity to direct expression in preimplantation development 
remains to be characterized. Two different enhancers have been identified for Oct4 
(Yeom et al., 1996; Yoshimizu et al., 1999). Strikingly, only one of them is able to 
direct reporter expression to the ICM of the blastocyst (the distal enhancer, Oct4DE). 
In contrast, the other enhancer is able to direct reporter expression in the epiblast 
and ES cells but not in the blastocyst. This suggests that the regulatory mechanisms 
that operate in vitro may not be equivalent to the mechanisms that operate in vivo. 
To better understand how the combinations of inputs affect the expression of the 
core set of transcription factors, we dissected the regulatory landscape of Cdx2. 
There have been a number of reports addressing Cdx2 regulation, but none of them 
were able to identify a TE-specific regulatory sequence (Benahmed et al., 2008; 
Gaunt et al., 2005; Wang and Shashikant, 2007). Here, we characterize the TEE, an 
enhancer that drives specific expression in the TE and that is expressed early during 
preimplantation development. Not only is the TEE found to be TE specific, but TEE 
mouse reporter lines also closely match the early onset of endogenous Cdx2 
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expression, highlighting its capacity to integrate resident regulatory signals. We 
cannot rule out an unspecific behaviour of the mouse reporter line due to positional 
integration effects of the transgene; however, the number of TEE mouse lines 
generated showing similar behaviour indicate that TEE reporter lines can be used as 
a read out of early events during the first lineage choice. 
Surprisingly, when we analysed TEE dynamics in TE-derived tissues, we found that it 
is not able to drive expression in the ExE of the post-implantation embryo, where 
Cdx2 is robustly expressed. The lack of TEE activity in the ExE led us to carefully 
analyse Cdx2 regulation in TS cells. In this context, the TEE cannot drive reporter 
expression when it is transfected into wild-type TS cells, and neither is it able to do 
so in TSL and TSR cell cultures, in which no reporter expression was detected. 
Histone mark profiling of the Cdx2 locus in wild-type TS cells reveals that the 
endogenous TEE is depleted of active marks and, in contrast, a region located in the 
first intron of Cdx2 shows positive regulatory capacity (Fragment II), suggesting that 
this sequence might be responsible for Cdx2 regulation in TS cells. This element is 
able to drive reporter expression in TS and ES cells, confirming its enhancer 
potential. Additionally, this fragment was previously reported in the lab to drive 
reporter activity in the blastocyst in transient transgenic assays in both ICM and TE. 
Nonetheless, its role in extraembryonic regulation of Cdx2 has yet to be 
characterized as it has only been shown to direct expression to mesoderm and 
neural tube in the post-implantation embryo (Wang and Shashikant, 2007). 
Preliminary data in the lab has shown that the fragment is able to direct 
extraembryonic mesoderm expression (data not shown), thus confirming its ability 
to drive expression to ICM-derived tissues. 
Altogether, these results indicate that the TEE holds TE-restricted capacity to drive 
reporter expression, whereas Fragment II activity is ubiquitous in the embryo. The 
fact that Fragment II retains activity in the whole blastocyst needs to be further 
investigated. It could be explained if inputs responsible for its regulatory ability 
appear equally in both tissues, leading to a general activation of the cis regulatory 
sequence, or if the DNA region is competent to respond to distinct inputs in 
different contexts. 
Here, we extensively tested the regulatory capacity of discrete cis-regulatory 
regions. In this way have we been able to identify regulatory elements that underlie 
Cdx2 regulation, but the regulatory mechanisms behind the regulatory landscape-
switch between TE and ExE remain unknown. The combinatory activity of several 
regulatory sequences may explain Cdx2 expression in the post-implantation 
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embryo. Generation of constructs that link TEE and Fragment II sequences will help 
us to study if we reproduce Cdx2 extraembryonic expression pattern completely or, 
in contrast, there are other cis-regulatory elements that remain to be further 
identified (Figure 34). 
During cleavage stages there is a transition from a stochastic expression of lineage 
factors to progressively restricted expression in their respective territories. In the 
first lineage choice, CDX2 is highly expressed in the outer population and defines 
the TE; in contrast, OCT4, SOX2 and NANOG will persist in the inside population and 
specify the ICM. This process involves at least two clear mechanisms to resolve the 
first lineage decision: the activation and reinforcement of the early expression of key 
transcription factors, followed by maintenance mechanisms that will ensure the 
lineage choice. 
The ability of the TEE to drive reporter expression concomitantly with the activation 
of endogenous Cdx2 expression indicates that the TEE sequence is responsible for 
receiving signals that activate Cdx2 at early stages. Not only does the TEE activity 
disappear once the TE starts to differentiate, but the TEE is also inactive in TS cells, 
in which Cdx2 is responsible for the self-renewal of the stem cell population 
(Strumpf et al., 2005). This suggests that the TEE is not involved in the maintenance 
of Cdx2 expression in TS-derived tissues or in the self-renewing capacity of TS cells. 
It is tempting to propose a two-stage regulatory model for Cdx2. In this model, the 
earlier establishment of Cdx2 expression would be mediated by the TEE, by reading 
stochastic and topological cues in the first lineage choice; in contrast, Cdx2 
expression at later stages would be maintained by other regulatory sequences 
active both in TS cells and in the post-implantation embryo, such as fragment II 
(Figure 34). 
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Figure 34. Two-stage regulation model of Cdx2. 
(A) Diagram of the Cdx2 locus showing cis-regulatory elements responsible for the 
initiation of Cdx2 expression (TEE, red circle) and later Cdx2 maintenance (blue 
triangles). Stochastic and morphology signals are integrated through the TEE 
whereas the regulatory element involved in Cdx2 maintenance remains to be 
unidentified. The dashed line denotes the possible action of the TEE as a cis-
regulatory element in combination with other sequences in later stages. (B) 
Proposed model for Cdx2 regulation in extraembryonic lineages. In early 
preimplantation development, the TEE regulates initial Cdx2 heterogeneous 
expression and restriction to the TE (in red). Upon implantation, Cdx2 regulation 
shifts to different cis-regulatory elements that maintain CDX2 expression in the ExE 
or TS cells. 
2. Notch and Hippo converge on Cdx2 regulation through the TEE. 
The Hippo signalling pathway has emerged as a fundamental player in the first 
lineage decision. This pathway translates topological cues related to compaction 
(cell adhesion and polarization) into a transcriptional response, its activation state 
differing between the prospective TE and the ICM according to the polarization of 
outer cells (Anani et al., 2014; Cockburn et al., 2013; Hirate et al., 2013). In the 
compact eight-cell stage embryo, YAP is in the nucleus and is able to interact with 
its transcriptional partner TEAD4, which is expressed in every cell. During the 
successive divisions, YAP is phosphorylated through LATS1/2 kinases and retained in 
the cytoplasm of inner cells, preventing its transcriptional activity. The 
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transcriptional mediator of Hippo signalling, TEAD4, has been characterized as an 
upstream regulator of Cdx2 at these early stages. 
Although it has been shown that the Hippo pathway regulates Cdx2 expression, we 
were able to detect occasionally Cdx2 expressed in Tead4 mutants, similar to what 
others have reported (Kaneko and DePamphilis, 2013; Nishioka et al., 2009). Also, 
the finding that initiation of Cdx2 expression is independent of compaction 
(Stephenson et al., 2010; Wu et al., 2010) and cell adhesion (Lorthongpanich et al., 
2013) suggests that further inputs are involved in Cdx2 regulation. We find that the 
TEE enhancer is still active and restricted to outer cells in Tead4 knockout embryos, 
confirming that other unknown regulatory mechanisms must regulate Cdx2 trough 
the TEE. 
In an effort to dissect how the Hippo pathway controls the TEE, we also tested if 
forced activation of the Hippo pathway in outer cells silenced the TEE. Forced 
expression of the Hippo pathway induces YAP phosphorylation and thus prevents it 
from shuffling to the nucleus to activate target genes. For these experiments, 
embryos of the mRFP-TEE line were injected with Lats2 RNA, which turns the Hippo 
pathway on and results in decreased expression of CDX2 in outer cells (Nishioka et 
al., 2009). This did not influence the expression of the reporter in the TE, confirming 
that the TEE does not respond exclusively to the activation state of the Hippo 
pathway in the blastocyst (results not shown). 
In the search for novel upstream regulators of Cdx2, dissection of the TEE sequence 
identified Notch as a candidate signalling cascade for Cdx2 regulation. Interestingly, 
as was the case for the Hippo pathway (Kaneko et al., 2007; Nishioka et al., 2008), 
we found that CDX2 levels are decreased in Rbpj mutants but the lack of Notch is 
not sufficient to turn TEE activity off. The requirements for Hippo and Notch 
pathways in the early embryo are clearly distinct, since Tead4 null embryos arrest 
development whereas Rbpj knockouts live up to 9.5dpc. Nonetheless, the relevance 
of the Notch pathway in cooperation with Tead4 is demonstrated by the finding 
that Rbpj and Tead4 double heterozygote mice have low CDX2 expression and 
compromised TEE capacity. Importantly, no double homozygous mutants for Tead4 
and Rbpj were detected. Compound mutants for Rbpj and Tead4 have below-
normal CDX2 expression levels per blastomere but do not show differences in cell 
number, suggesting that additional regulatory inputs act on Cdx2 in the blastocyst. 
A possible mechanism is auto-regulation of Cdx2 (Barros et al., 2011; Cockburn and 
Rossant, 2010; Niwa et al., 2005), which would maintain and stabilize Cdx2 
expression levels. 
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Analysis of the response of the TEE to Hippo and Notch showed that RBPJ and TEAD 
compensate for each other, since TEE activity is reduced only when the binding sites 
for one pathway have been mutated and the converse pathway is inhibited, or when 
binding sites for both are mutated. Thus, Notch and Hippo operate such that the 
TEE is capable of driving reporter expression if at least one of its upstream 
regulators is on. With this finding, not only have we identified Notch as a novel 
upstream regulator of Cdx2, but we also show the convergence of Notch and Hippo 
on a specific regulatory sequence. The structure of the Cdx2 TE-enhancer described 
here can be used to screen for cis-regulatory elements with a similar organization of 
RBPJ and TEAD sites and thereby identify other components of the TE-specification 
gene regulatory network. 
Previous reports of Notch and Hippo interaction have shown that one pathway is 
downstream of the other in Drosophila (Chen et al., 2011; Graves et al., 2012) and in 
liver development and cancer (Tschaharganeh et al., 2013; Yimlamai et al., 2014). It 
will be important to study if there is any other crosstalk of the pathways during pre-
implantation development; in this regard, it is interesting that in Drosophila wing 
epithelial cells, inactivation of Hippo signalling results in apical accumulation of the 
Notch receptor (Genevet et al., 2009). Moreover, it should be noted that phenotypes 
of mutations of Notch pathway components are sensitive to gene dosage 
(Murtomaki et al., 2013; Nus et al., 2011) (Boyer-Di Ponio et al., 2007). 
The results of this study show that the Hippo and Notch pathways act through the 
TEE and converge to activate the expression of Cdx2 during the first lineage 
specification in the blastocyst. In the developing TE, the Hippo pathway is off and 
YAP translocates to the nucleus and binds to TEAD4 to activate target genes. At the 
same time, the Notch signalling pathway is active in the TE, and N1ICD is therefore 
in the nucleus bound to RBPJ and activating Cdx2 expression (Figure 35). 
Consistent with what we found in the blastocyst, N1ICD is heterogeneously 
expressed in TS cells, whereas we do not detect N1ICD expression in ES cells. In 
striking contrast, ES cells derived from the H2B:CBF-Venus reporter line still express 
the reporter (Nowotschin et al., 2013). We did not assess the presence of other 
Notch receptors so we cannot rule out the possibility that these (Notch2-4) are 
active in ES cells. Additionally, persistent expression of the reporter in ES cells may 
reflect the fact that ES cells are not equivalent to ICM cells, and in fact represent 
epiblast cells from 4.5 dpc blastocysts (Boroviak et al., 2014). 
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Figure 35. Notch and Hippo converge on Cdx2 to specify 
trophectoderm lineage. 
Representation of the signalling pathways that act through the TEE to regulate 
Cdx2. In TE cells, the Hippo pathway is OFF and thus unable to retain YAP in the 
cytoplasm, and the Notch pathway is ON. YAP coactivator and NOTCH1 intracellular 
domain (N1ICD) respectively bind to TEAD4 and RBPJ to activate Cdx2 transcription. 
Overexpression of TE factors (Cdx2, Gata3, Ras, Tead4) in ES cells transdifferentiates 
them to TS cells (Lu et al., 2008; Nishioka et al., 2009; Niwa et al., 2005; Ralston et al., 
2010). However, inhibition of Hippo signalling in ES cells, while resulting in a loss of 
pluripotency, does not appear to convert ES cells into a TE fate, but rather promotes 
differentiation to endodermal (Lian et al., 2010; Tamm et al., 2011). As ES cells do 
not reproduce the blastocyst environment, it is conceivable that YAP responds in a 
different manner. Recently, cues from the extracellular matrix, cell adhesion sites, 
cell shape and the actomyosin cytoskeleton have been found to converge on the 
regulation of YAP (Halder et al., 2012). Notch over-activation in ES cells does not 
induce any phenotypic change; it is only upon withdrawal of self-renewal stimuli 
that Notch overexpression induces a rapid and exclusive differentiation into the 
neural lineage (Lowell et al., 2006). This does not contradict our findings, but rather 
indicates that Notch operates differently in ES cells versus the ICM, as is also the 
case for the Hippo pathway. 
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3. Notch signalling in the first lineage choice. 
During the first fate choice, there is a crucial shift from a random expression of 
transcription factors to a coordinated response to morphological cues provided by 
the physical properties of the embryo. At the time of compaction, interconnected 
features such as polarization, cell adhesion and cell to cell interaction are integrated 
into the modulation of the transcriptional program of single blastomeres (Cockburn 
and Rossant, 2010; Hirate et al., 2013). What is really intriguing is that at the 
transcriptional level, not all blastomeres exposed to near-identical cues (for 
instance, blastomeres in outside positions) respond equally, while blastomeres 
exposed to different morphological cues (for example outside versus inner 
blastomeres) sometimes do, as shown by the stochastic expression of the core 
transcription factors (Dietrich and Hiiragi, 2007; Ralston and Rossant, 2008). This 
observation is also supported by the fact that outer cells as early as the 16-cell stage 
are a heterogeneous population, with some fated to contribute exclusively to the TE 
and others able to form both the TE and ICM (Anani et al., 2014; Watanabe et al., 
2014). In this context, the adoption of either TE or ICM programs is a regulative 
decision, and the final output of key transcription factors may rely on subtle 
differences within blastomeres. It is thus vital to characterize adjusting mechanisms 
by which key transcription factors respond to single inputs but modulate their 
expression coordinately. In this complex framework, understanding of 
compensation, cooperation and redundancy among signalling pathways will help us 
to better dissect the first lineage choice. 
Cdx2 exhibits two distinct patterning phases that eventually lead to its TE-restricted 
expression. In the first phase, molecular differences between blastomeres are 
generated (initiation of Cdx2 expression and establishment of variability among 
blastomeres), and in the second phase, molecular signature responds to cell 
allocation within the embryo (Dietrich and Hiiragi, 2007). It has become clear that 
the second patterning phase of Cdx2 relies on the Hippo pathway, which connects 
positioning and transcription factors (Cockburn and Rossant, 2010; Hirate et al., 
2013). We have identified the Notch pathway as a signalling mechanism that 
modulates TE specification, and we show that Notch not only subtly alters Cdx2 
levels, but also influences the fate of blastomeres by driving them to outer positions 
in the embryo when overexpressed. It could be argued that Notch simply elevates 
Cdx2 levels and that this is the trigger for cell relocation (Jedrusik et al., 2008). 
However, the fact that blastomeres mutant for Cdx2 can adopt an outer position 
argues against this possibility (Ralston and Rossant, 2008). Hence, we propose that 
the Notch pathway could be involved in the initiation of Cdx2 expression. In this 
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way, Notch and Hippo would cooperate in Cdx2 regulation in an overlapping 
temporal framework in which Notch would introduce the first random 
transcriptional expression among cells and Hippo would be responsible for fixing 
the levels according to the cells’ molecular signature (positional and polarization 
state) (Figure 36). The fact that Notch pathway mouse mutants (Rbpj, Notch1-4 
receptors and ligands) do not show a severe preimplantation phenotype may 
indicate compensatory roles among this family of receptors. Nevertheless, two 
reports have described deleterious defects during early development in the Notch 
pathway components Notchless (Cormier et al., 2006) and Brainiac (Vollrath et al., 
2001), supporting a role for this signalling pathway. 
Notch signalling can operate through two possible mechanisms: lateral inhibition, 
which generates heterogeneity from an otherwise homogenous group of cells 
(Artavanis-Tsakonas et al., 1999), and lateral induction, which achieves local 
homogeneity of cells expressing receptors and ligands and enables cells to create a 
sharp gene expression boundary where no such discontinuity existed before (Lewis, 
1998) (Figure 7). 
Lateral inhibition operates such that the signalling cell and the adjacent receiving 
cell induce opposite transcriptional effects. Among apparently equivalent 
neighbours expressing both ligand and receptor, a small increase in ligand in one 
cell relative to its neighbour could favour its adoption of the signalling role. The 
signalling cell induces Notch activation on the adjacent cell. As a result, Notch 
reduces ligand expression in the receiving cell, preventing the activation of Notch in 
the signalling cell and thus generating an opposite response. Feedback then 
amplifies and consolidates the differences between receptor and ligand. In this way, 
the adjacent cells will manifest complementary expression patterns that lead to the 
generation of distinct populations in an initially identical field. In the early embryo, 
the stochastic expression of Cdx2, Sox2 and Nanog precedes the first lineage choice 
and there is still not a good understanding of how this noisy system starts. Lateral 
inhibition could drive the first wave of stochastic Cdx2 expression in a polarization- 
and adhesion-independent manner. In this context, random expression of Notch 
would elevate Cdx2 expression accordingly and downregulate the expression of 
Notch ligands within the cell. Cell-to-cell interactions through lateral inhibition 
instruct the neighbouring cell to have the opposite effect and thus generate the first 
heterogeneities in an equivalent population (Figure 36). In this scenario, Notch 
ligand and receptor distributions should be complementary, and it will also be 
interesting to analyse the number of CDX2+ adjacent cells and how CDX2 correlates 
with early N1ICD expression. 
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If lateral induction functions in the blastocyst, it would lead to cells of the TE acting 
as a coherent group, in other words a developmental field. Sustained activity of the 
pathway in outer cells ensures that they maintain a TE fate, allowing for correct 
specification of blastomeres that reposition during cell division and normalizing the 
early stochastic expression pattern –underpinning Hippo pathway function. 
Validation of lateral induction requires testing of whether Notch itself inhibits or 
induces expression of the Notch-activating ligand. So far, we have identified Dll1 
expression in cells of the trophectoderm at the blastocyst stage (results not shown), 
but other components need to be further investigated. The observed co-expression 
of the activated Nocth1 receptor and the ligand Dll1 in cells of the trophectoderm 
suggests that Notch acts in the blastocyst through a mechanism of lateral induction 
rather than through lateral inhibition, although no mechanism can yet be ruled out 
(Figure 36). 
As previously mentioned, Notch receptor activity relies on cell-to-cell signalling 
interaction through its ligands. In our study, we have limited our analysis to Notch 
function in the blastocyst. It will be interesting to assess the requirement for Notch 
pathway in the morula, during the first wave of expression of core transcription 
factors, to test for a Notch-mediated TE-specification model. In this model, lateral 
inhibition is responsible for the early stochastic expression of transcription factors, 
and later the stabilization of the lineages occurs as a result of the convergence of 
Hippo and Notch signalling through lateral induction (Figure 36). If this is the case, 
we predict that Notch mutants will not show Cdx2 stochastic expression early on 
but that the reinforcement signals through Hippo would still raise Cdx2 levels so 
that the regulative embryo develops. This view fits with the observation that Cdx2 
levels were reduced but still enough to specify the TE in Rbpj mutants. The model 
could also explain why the double Tead4; Rbpj mutant embryos die: they would lack 
both the initiation of random Cdx2 expression and the reinforcement mechanisms 
needed to stabilize Cdx2 expression. A clearer understanding of whether Notch has 
an overall effect on the TE transcriptional program could be gained from genome-
wide RNA analysis of different Notch mutants and gain-of-function strains. Also, 
inducible Cre/loxP strategies that allow us to generate mosaic expression of Notch 
receptors and ligands will help to unravel the role of Notch in TE specification. 
If we consider the embryo as a self-organizing system (Wennekamp et al., 2013), 
lineage establishment is initiated, corrected and refined by a combination of 
intrinsic and extrinsic cues. In this scenario, the robustness of TE establishment is 
conferred through the initiation and fine tuning of combinatorial inputs that drive 
the expression of TE-lineage markers such as Cdx2. The overlapping activities of 
DISCUSSION
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Notch and Hippo pathways are likely integrated via regulatory elements such as the 
TEE, and could underlie the regulatory capacities of the mammalian embryo and the 
initial stochastic lineage-specific transcriptional programs. Future work will provide 
information about how modulation of Notch together with other signalling 
pathways leads to the differentiation of the totipotent cell, and how symmetry is 
first broken during mammalian development. 
 
Figure 36. Temporal control of TE specification through the Notch 
and Hippo pathways. 
Proposed temporal patterning phases for TE specification. In the early phase, the 
Notch pathway generates molecular differences between blastomeres and 
upregulates Cdx2 through lateral inhibition. In the second phase, the Hippo 
pathway translates topological cues related to compaction into a transcriptional 
response, while Notch reinforces Cdx2 expression in outer cells via lateral induction. 
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"And at last we've got to the end of this ideal racecourse!  
Now that you accept A and B and C and D, of course you accept Z." 
What the Tortoise Said to Achilles. LEWIS CARROLL. 
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CONCLUSIONS    
» We have identified a 1.3 kb trophectoderm-specific enhancer (TEE) located 3 kb 
upstream of the mouse Cdx2 gene. 
» Expression of reporter genes driven by the TEE reproduce the early activation of Cdx2 
expression at the morula stage and trophectoderm restricted expression in the 
blastocyst. 
» The TEE does not drive expression in trophectoderm-derived tissues of the post-
implantation embryo or in trophoblast stem cells, suggesting a two-stage regulatory 
mechanism for Cdx2 expression in the early embryo. 
» The TEE does not respond only to Tead4, indicating that other regulatory inputs are 
responsible for Cdx2 early expression. 
» The Notch pathway directly regulates Cdx2 expression in combination with Tead4 
through the TEE. 
» Activity of the Notch pathway is restricted to the trophectoderm of the blastocyst. 
» The Notch pathway, together with Tead4, is essential for preimplantation 
development. 
» Notch overexpression influences the position of cells in the blastocyst and drives 
them to preferentially allocate to the trophectoderm. 
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CONCLUSIONES    
» Hemos identificado un enhancer de 1,3 kilobases específico de trofectodermo (el 
TEE), localizado 3 kilobases por delante del gen Cdx2. 
» Las expresión de genes reporteros dirigida por el TEE reproduce la activación 
temprana de la expresión de Cdx2 en el estadio de morula y su expresión restringida 
en el trofectodermo del blastocisto. 
» El TEE no dirige la expresión en tejidos derivados del trofectodermo en estadios de 
post-implantación ni en células troncales del trofoblasto. Esto sugiere un mecanismo 
de regulación en dos etapas para la expresión de Cdx2 en el embrión temprano. 
» El TEE no responde únicamente a Tead4, lo que indica que otras vías regulan la 
expresión temprana de Cdx2. 
» La vía de Notch regula directamente la expresión de Cdx2 junto con Tead4 través del 
TEE. 
» La actividad de la vía de Notch está restringida al trofectodermo del blastocisto. 
» La vía de Notch, junto con Tead4, es esencial para el desarrollo en preimplantación. 
» La sobreexpresión de Notch influye en la posición de las células en el blastocisto y las 
orienta preferencialmente al trofectodermo. 
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SUPPLEMENTARY TABLES    
Table A. Key transcription factors implicated in ICM and TE differentiation. 
Name 
Initial expression 
and localization 
Knock-out 
phenotype 
Gain of function 
phenotype 
Reference 
TE specific transcription factor 
Cdx2 
mRNA found at 
eight-cell stage. 
Nuclear protein 
detected at eight-
cell stage. Mosaic 
early expression, 
TE-restricted at 32-
cell stage 
Die at blastocyst 
stage (zygotic and 
maternal/zygotic 
mutants). 
Epithelial integrity 
loss. 
Cavitation fail. 
TE expresses ICM 
markers. 
Overexpression in 
ES cells turns 
them to TS cells. 
(Blij et al., 2012; 
Chawengsaksophak 
et al., 1997; Dietrich 
and Hiiragi, 2007; 
Jedrusik et al., 2008; 
Niwa et al., 2005; 
Ralston and Rossant, 
2008; Strumpf et al., 
2005; Wu et al., 
2010) 
Tead4 
Muclear protein 
detected at 4 cell 
stage. 
Ubiquitous 
(TE+ICM). 
Embryos do not 
form a blastocyst. 
Loss of Cdx2 and 
Gata3 expression. 
Overexpression of 
Tead4 active form 
in ES cells turns 
them to TS cells. 
(Nishioka et al., 
2009; Nishioka et al., 
2008; Yagi et al., 
2007) 
Yap 
Detected at 4 cell 
stage 
Nuclear in outer 
cells, cytoplasmic in 
inside cells. 
Cytoplasmic in ICM, 
nuclear in TE. 
Die at 8.5dpc. 
Defects in Yolk Sac, 
chorioallantoic 
fusion, and 
embryonic axis 
elongation. 
Overexpression in 
inner cells of 
blastocyst induces 
Cdx2 expression. 
(Morin-Kensicki et 
al., 2006; Nishioka et 
al., 2009) 
Gata3 
Nuclear protein 
detected at 16 cell 
stage. Outer cells, 
prospective TE cells 
and TE. 
Die at 11.5dpc from 
massive internal 
bleeding and 
placental defects. 
Overexpression in 
ES cells turns 
them to TS cells. 
(Home et al., 2009; 
Pandolfi et al., 1995; 
Ralston et al., 2010) 
Eomes 
Nuclear protein 
detected at 
blastocyst stage. 
TE specific. 
Embryos fail to 
implant. TE 
differentiation 
blocked. TE still 
expresses Cdx2. 
Overexpression in 
ES cells turns 
them to TS cells 
but they 
spontaneously 
differentiate. 
(Niwa et al., 2005; 
Ralston and Rossant, 
2008; Russ et al., 
2000; Strumpf et al., 
2005) 
Klf5 Nuclear protein Embryos do not Expression in ES (Lin et al., 2010) 
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detectable at two 
cell stage. 
Ubiquitous early. 
Strong in TE, weak 
in ICM. 
form blastocysts. 
Loss of Cdx2 but TE 
and ICM specified 
cells permits LIF 
independent self-
renewal. 
Tcfap2c 
Suggested maternal 
expression. Late 
morula and 
blastocyst (not 
analysed earlier). 
Ubiquitous early 
and late expression 
(TE+ICM). 
Die at 7.5 dpc with 
extraembrionary 
defects. Cdx2 and 
Eomes reduced 
expression. 
N/A (Auman et al., 2002) 
ICM genes 
Oct4 
Maternal expression. 
Nuclear zygotic 
protein detected at 
eight cell stage. 
Ubiquitous initially; 
ICM restricted at 
4.5dpc. 
Morphological 
normal blastocyst. 
ICM expresses TE 
markers at 4.5dpc. 
Role in Epi/PE 
segregation 
OCT4 
overexpression in 
tissues facilitates 
reprogramming 
by interfering with 
the somatic 
transcriptional 
network. 
(Frum et al., 2013; Le 
Bin et al., 2014; 
Nichols et al., 1998; 
Tiemann et al., 2014) 
Sox2 
Nuclear protein 
detected at eight 
cell stage. 
Mosaic expression. 
In blastocysts 
Cytoplasmic in TE 
and nuclear in ICM. 
Homozygotes for 
targeted null 
mutations implant 
but fail to develop 
an egg cylinder or 
epiblast, and die 
shortly thereafter. 
If overexpressed 
in ES or TS 
safeguards the 
stem cell state 
(together with 
some other 
specific sets of 
genes). 
(Adachi et al., 2013; 
Avilion et al., 2003) 
Nanog 
Nuclear protein 
detected at eight 
cell stage. 
Mosaic early 
expression. 
ICM/epiblast 
restricted. 
Required for EPI 
formation and 
germ line 
reprogramming. 
Expression in ES 
cells permits LIF 
independent self-
renewal. 
(Chambers et al., 
2003; Dietrich and 
Hiiragi, 2007; Mitsui 
et al., 2003) 
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Esrrb 
ICM expression (Not 
assessed earlier). In 
post-implantation 
development 
located in the 
Extraembryonic 
ectoderm. 
Die around 9.5dpc. 
Failure of the 
chorion to develop 
and subsequent 
placental defect. 
Expression in ES 
cells permits LIF 
independent self-
renewal. 
(Luo et al., 1997; 
Martello et al., 2012) 
 
  
 
 
 
 
 
 
Table B. Distribution (%) of embryos for the different allelic combinations. 
Rbpj +/+ +/+ +/- +/- +/+ -/- +/- -/- -/- 
 Tead4 +/+ +/- +/+ +/- -/- +/+ -/- +/- -/- total 
no.embryos 
(%) 
13 
(16,88%) 
10 
(12,98%) 
10 
(12,98%) 
18 
(23,37%) 
2 
(2,59%) 
7 
(9,09%) 
8 
(10,39%) 
9 
(11,69%) 0 77 
expected % 6,25% 12,50% 12,50% 25,00% 6,25% 6,25% 12,50% 12,50% 6,25% 100,00% 
 
 119 
PUBLICATIONS    
This work has led to the publication of the following article: 
Rayon T., Menchero S., Nieto A., Xenopoulos P., Crespo M., Cockburn K., Canon S., 
Sasaki H., Hadjantonakis A.K., de la Pompa J.L., Rossant J., Manzanares, M (2014). 
Notch and Hippo converge on Cdx2 to specify the trophectoderm lineage in the 
mouse blastocyst. Dev Cell. 2014 Aug 25;30 (4)410-22. 
The collaboration in other research projects during the development of the thesis 
has resulted in the following publications: 
Pernaute B, Cañon S, Crespo M, Fernandez-Tresguerres B, Rayon T, Manzanares M 
(2010). Comparison of extraembryonic expression of Eomes and Cdx2 in pre-
gastrulation chick and mouse embryo unveil regulatory changes along evolution. 
Dev Dyn 239, 620-629. 
Fernandez-Tresguerres B, Cañon S, Rayon T, Pernaute B, Crespo M, Torroja C, 
Manzanares M (2010). Evolution of the mammalian embryonic pluripotency gene 
regulatory network. PNAS 107, 19955-19960.  
Peralta M, Steed E, Harlepp S, González-Rosa JM, Monduc F, Ariza-Cosano A, Cortés 
A, Rayón T, Gómez-Skarmeta JL, Zapata A, Vermot J, Mercader N (2013). Heartbeat-
driven pericardiac fluid forces contribute to epicardium morphogenesis. Curr Biol. 
2013 Sep 23;23(18):1726-35. 
Abad M, Mosteiro L, Pantoja C, Cañamero M, Rayon T, Ors I, Graña O, Megías D, 
Domínguez O, Martínez D, Manzanares M, Ortega S, Serrano M (2013). 
Reprogramming in vivo produces teratomas and iPS cells with totipotency features. 
Nature. 2013 Oct 17;502(7471):340-5  
